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Pluripotency maintenance and embryo patterning are key events of early embryogenesis. 
Transcription factors Nanog, Oct4 and Sox2 constitute a core circuit for regulating 
pluripotency in mouse embryonic stem (ES) cells and early developing embryos. 
However, zebrafish Pou2, homolog of mammalian Oct4, is a maternal determinant for 
dorsoventral patterning. Nanog shows extensive sequence divergence, producing an as 
low as 26% identity between mammals and chicken. Whether nanog exists and plays a 
conserved role in pluripotency or patterning in lower vertebrates, in particular in fish, the 
ancient vertebrate lineage, has been unclear. This work was aimed at the identification, 
expression and function of nanog in the medaka and zebrafish as excellent models for 
analyzing pluripotency and patterning. 
 The medaka and zebrafish nanog termed Ong and Zng respectively, encode proteins 
of 420 amino acids (aa, Ong) and 384 aa (Zng), which exhibit a best but 16-18% low 
sequence identity to tetrapod Nanog and lacks chromosomal synteny to tetrapod 
vertebrates. It has, however, the conserved 4-exon structure and a unique motif. The 
homology between fish and mouse nanog genes was established by the experiments 
where the mouse nanog can produce gain-of-function phenotype and rescue the 
loss-of-function phenotype in both fish species.  
In vivo, Ong is expressed throughout the pluripotency cycle, including the zygote 
and germline. In vitro, Ong RNA and protein are high in ES cells and down-regulated 
upon differentiation. Importantly, forced Ong expression supported ES cell proliferation 
under differentiation conditions. Upon zygotic RNA injection, Ong overexpression 
affected blastomeres proliferation, whereas Ong interference by dominant-negative 
mutants or morpholino-based knockdown compromised cell divisions and lineage 
commitment, leading to gastrula arrest as well as to the loss of yolk vein and tail defects. 
Strikingly, despite extensive sequence divergence and chromosome rearrangements, 
medaka nanog possesses the conserved role in pluripotency maintenance at early stages 
and previously unidentified roles in late stages. 
Zng exhibits a similar expression pattern to Ong with a salient difference: in contrast 
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to restricted Ong expression in the central blastomeres, Zng distributes in all blastomeres. 
Zng knockdown led to strongly dorsalized embryos and other profound defects including 
eyeless phenotype, loss of yolk vein and tail defects. Zng knockdown led to severe 
reduction in the early zygotic expression of ventralizing genes (vox, ved and vent), 
dorsoventral patterning gene pou2 and neuroectodermal genes (pax2.1 and pax6.1) and to 
the expanded expression of the mesendodermal gene ntl (no tail). Therefore, similar to 
zebrafish Pou2, Zng becomes another determinant for dorsoventral patterning in early 
embryogenesis. 
In conclusion, nanog plays an essential role in pluripotency maintenance in medaka 
but in dorsoventral patternining in zebrafish. This striking finding provides direct 
evidence for functional conservation and divergence or pleiotropism of a patterning or 




























List of Figures and Tables 
 
Fig. 1-1 Schematic diagram showing embryonic cell lineage and derivation of stem 
cells. 
3 
Fig. 1-2 Models of core transcription networks containing Oct4, Sox2 and Nanog 9 
Fig. 1-3 Nanog mRNA is confined to pluripotent/multipotent cells 19 
Table 1-1 Summary of nanog expression pattern 20 
Fig. 1-4 Regulation of Nanog by other transcription factors 25 
Fig. 1-5 Alignment analysis of homeodomains from various homeoproteins 30 
Fig. 1-6 Nanog domain structure 31 
Fig. 1-7 The phylogeny of vertebrates 34 
Fig. 1-8 Zebrafish fate maps 40 
Fig. 1-9 Transcriptional interactions patterning the dorsal-ventral axis 44 
Fig. 3-1 PCR cloning of the Ong cDNA  71 
Fig. 3-2 Ong cDNA sequence with deduced anmino acid sequence 72 
Fig. 3-3 Alignment of homeodomains of Nanog with related Nkx and Vent family 73 
Fig. 3-4 Genomic organizations of nanog, vent and nkx2.5 74 
Fig. 3-5 Protein domain structure of Nanog 75 
Fig. 3-6 Phylogenetic tree of Nanog 76 
Fig. 3-7 Chromosomal location and synteny analysis of Ong 78 
Fig. 3-8 RT-PCR analysis of Ong 80 
Fig. 3-9 Ong mRNA expression in oocytes and oogonia of adult ovary 82 
Fig. 3-10 Ong RNA expression in adult testis 83 
Fig. 3-11 Ong RNA expression during early embryogenesis until gastrulation 85 
Fig. 3-12 Ong RNA expression in primordial germ cells 86 
Fig. 3-13 Ong protein presents in gonads and ES cells 88 
Fig. 3-14 Nanog protein expression and nuclear localization in medaka ES cells and 
embryos 
89 
Fig. 3-15 Ong protein localization in oocytes. 91 
Fig. 3-16 Ong protein is localized to vasa positive germ cells from male fry 92 
Fig. 3-17 Ong protein colocalizes with vasa in female germ cells 92 
Fig. 3-18 Ong expression is sufficient to prevent ES cell differentiation 95 
Fig. 3-19 Ong expression is sufficient for clonal expansion of ES cells in the 
absence of growth factor bFGF 
96 
Fig. 3-20 ES cell differentiation is associated with loss of Ong expression  97 
Fig. 3-21 DNM analysis of Ong in early development by injection of OngDN2 100
Fig. 3-22 DNM analysis of Ong in early development by injection of OngDN3 101
Table 3-1 Dose-dependent phenotypes by OngMO knockdown 104
Fig. 3-23 Examination of OngMO1 specificity 105
Fig. 3-24 Classification of phenotypes caused by OngMO1 knockdown 107
Fig. 3-25 Phenotype class IV caused by OngMO 108
 ix
Fig. 3-26 Rescue of OngMO phenotype by mouse nanog mRNA 110 
Fig. 3-27 Ong knockdown affects blastula cell fate 113 
Fig. 3-28 Ong knockdown led to down-regulation of pou2 and up-regulation of ntl 113 
Fig. 4-1 Zng cDNA sequence with deduced anmino acid sequence 124
Fig. 4-2 Spatial and temporal expression of Zng 125
Fig. 4-3 Zng RNA expression in adult tissues 126
Fig. 4-4 Zng mRNA is maternally supplied 127
Fig. 4-5 Zng RNA expression in early embryonic stages from MBT to 24 hpf 128
Table 4-1 Dose-dependent phenotypes caused by MO1 knockdown 130
Fig. 4-6 Phenotypes caused by Zng MO knockdown 131
Fig. 4-7 Zng knockdown leads to gastrulation defects 132
Table 4-2 Phenotypic rescue by medaka and mouse nanog 133
Fig. 4-8 Eyeless phenotype can be rescued by Ong mRNA injection 134
Fig. 4-9 Eyeless phenotype can be rescued by mouse nanog mRNA injection 135
Fig. 4-10 Expression of vox, vent and ved by Zng MO1 knockdown 138
Fig. 4-11 Expression of pou2 (oct4) and gsc by Zng MO1 knockdown 139
Fig. 4-12 Mesodermal markers ntl and brachyury were misexpressed in Zng 
morphants at 80% epiboly 
140
Fig. 4-13 Expression of pax6.1 and pax2.1 in eye field was lost in morphants 141
Fig. 5-1 Nanog regulates different set of genes to control pluripotency or 
patterning 
149


























List of Abbreviations 
 
A-P     Antero-posterior 
AP      Alkaline phosphatatse 
APS     Amomonium persulfate 
BCIP    5-bromo, 4-chloro, 3-indolylphosphate 
BMP    Bone Mophogenetic Protein 
bp      Base pairs 
BSA     Bovine serum albumin 
cDNA   DNA complementary to RNA 
CMV    Cytomegalovirus 
DV     Dorso-Ventral 
DEPC   Diethyl pyrocarbonate 
DIG     Digoxygenin 
DNM    Dominant negative mutant 
DNA    Deoxyribonucleic acid 
dNTP    deoxyribonucleotide triphosphate 
DTT    Dithiothreitol 
EDTA   Ethylene diamine tetraacetic acid 
Eomes   Eomesodermin 
eGFP    enhanced green fluorescent protein 
F       Phenylalanine 
ERM    Embryo rearing medium 
FBS     Fetal bovine serum 
ESM4   ES cell medium 4 
FCS     Fetal calf serum 
FGF     Fibroblast growth factor 
Gsc     Goosecoid 
GSK3-β  Glycogen Synthase Kinase 3β 
hfp      hours post fertilization 
HRP    Horseradish peroxidase 
ISH in situ hybridization 
K       Lysine 
kb      kilobase 
LB      Luria-bertani medium 
Lef      Lymphoid enhancing factor transcription factor 
LiCl     Lithium Chloride 
MO     Morpholino oligo 
MOPS   3-(N-morpholino) propanesulfonic acid 
MES1   Medaka embryonic stem cell line 1 
mRNA   messenger RNA 
 xi
N       Asparagine 
NBT    nitro blue tetrazolium chloride 
Ntl      No tail 
NTP     ribonucleotide triphosphate 
Ol      Oryzias latipes 
Ong     Medaka nanog 
ORF    Open reading frame 
PAGE   Polyacrylamide gel electrophoresis 
PBS     Phosphate buffered saline 
PCR     Polymerase chain reaction 
pCVpf   CMV promoter-driven expression of puromycin and GFP
pCVpr   CMV promoter-driven expression of puromycin and RFP 
PGC    Primodial germ cell 
PFA     Paraformaldehyde  
POD    Peroxidase enzyme 
PTK     Proteinase K  
PTW    PBS with 0.1% Tween-20 
Q       Glutamine 
RACE   Rapid amplification of cDNA ends 
RNA    Ribonucleic acid 
RFP     Red fluorescent protein, DsRed 
RT-PCR Reverse Trancriptase Polymerase Chain Reaction 
SDS     Sodium dodecylsulfate 
SG3     Spermatogonial stem cell line 3 
SSC     Sodium chloride tri-sodium citrate solution 
T       Threomine 
TAE     tris-acetate EDTA 
TBS     Tris buffered saline 
TBST   Tris buffered saline with 0.1% Tween-20 
Tcf      T-cell factor 
TSA     Tyramide tignal amplification 
TEMED N,N,N’,N’-tetramethylethylene diamine 
V       Valine 
WISH   Whole mount in situ hybridization 
W      Tryptophan 
Y       Tyrosine 
YSL     Yolk syncytial layer 











1. Hongyan Xu, Zhendong Li, Mingyou Li, Li Wang, Yunhan Hong. 2009. 
Boule Is Present in Fish and Bisexually Expressed in Adult and 
Embryonic Germ Cells of Medaka. PLoS One, 4(6):e6097.  
 
2. Lixiu Liu, Ni Hong, Hongyan Xu, Mingyou Li, Yan Yan, Yovita Purwanti, 
Meisheng Yi, Zhendong Li, Li Wang and Yunhan Hong. 2009. Medaka 
dead end encodes a cytoplasmic protein and identifies embryonic and 
adult germ cells. Gene Expr Patterns. 2009 Jul 3. [Epub ahead of print] 
  
3. Zhendong Li & Yunhan Hong. 2009. Nanog from fish to mammals: 
Sequence divergence accompanies function conservation in maintaining 
pluripotency. Prepared. 
 
4. Zhendong Li & Yunhan Hong. 2009. Nanog is a maternal determinant of 




1. Zhendong Li & Yunhan Hong. 2004. Conservation of PDX1 structure and 
expression in medakafish. The 5th Human Genetics organization (HUGO) 
Pacific Meeting & 6th Asia-Pacific Conference on Human Genetics. 
 
2. Zhendong Li & Yunhan Hong. 2006. Identification of a lower vertebrate 
nanog and its pluripotency-associated expression in medakafish. The 11th 



















Chapter I: Introduction 
1.1 Embryogenesis and stem cells 
Vertebrate embryogenesis is a process involved in fertilization, cleavage, blastula, 
gastrula, somitogenesis, morphogenesis and organogenesis; at last an embryo forms 
and develops to a fetus. During this process, a single totipotent zygote undergoes 
lineage specification, commitment and differentiation to generate about 220 cell types 
including the germ line. In mouse, only the fertilized oocyte and blastomere cells of 
embryos at the 2- to 8-cell stage are capable of generating a fully viable organism and 
therefore are regardesd as totipotent (omnipotent) cells. Pluripotent stem cells (PSCs) 
cannot re-create a complete organism but can contribute to all the different cell types 
in the body. PSCs include embryonic stem (ES), embryonic germ (EG), embryonic 
carcinoma (EC) cells and recently identified spermatogonial stem cells (SSCs) 
(Conrad et al., 2008; Guan et al., 2006; Yu and Thomson, 2008). PSCs are derived 
from different stages of a developing embryo and normally express pluripotent genes 
Oct4 and Nanog (Fig. 1-1). As embryo development proceeds and a stem cell 
becomes committed to a specific lineage and decreases its proliferative potential, it is 
usually described as a progenitor cell. Adult stem cells, which are isolated from 
certain adult tissues, are capable of forming multiple cell types but are believed to 
have a more limited potential than pluripotent stem cells.  
Stem cells are undifferentiated cells capable of proliferation and self-renewal and 
have the capacity to differentiate into specific cell types. Stem cells have been a very 
powerful tool in developmental biology and hold great promise for regenerative 
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medicine. Stem cells are isolated from developing embryos or adult tissues.  
Nanog is a novel homeodomain containing transcription factor and is 
predominantly expressed in pluripotent cells in vivo and vitro (Chambers et al., 2003; 
Mitsui et al., 2003). Mouse embryos depleted of Nanog failed to generate epiblast and 
only form disorganized extra-embryonic endoderm tissues. ES cells lacking Nanog 
spontaneously differentiate into primitive endoderm. Constitutive over-expression of 
Nanog can confer ES cells self-renewal ability in the absence of LIF or feeder layers 


























Fig 1-1 Schematic diagram showing embryonic cell lineage and derivation of 
stem cells. Oct4 is required for ICM formation and Nanog is required for epiblast 
formation. ICM, inner cell mass; PGCs, primordial germ cells; ESCs, emryonic stem 
cells; TSCs, trophoblast stem cells; EpiSCs, epiblast stem cells; EG, embryonic germ 
cells; SSCs, spermatogonial stem cells; AS, adult stem cells; HSC, hematopoietic 
stem cells; NSC, Neural stem cells; MSC, mesenchymal stem cells. Adapted from 







1.1.1 Embryonic stem cells 
Embryonic stem (ES) cells are pluripotent stem cell lines derived from 
pre-implantation embryos and can be propagated as an uncommitted cell population 
for an almost unlimited period without losing their pluripoency and their stable 
karyotype. The term ‘ES cell’ was introduced to distinguish these embryo-derived 
pluripotent cells from teratocarcinoma-derived pluripotent embryonal carcinoma (EC) 
cells. ES cells/pluripotent cells have the following properties: 
1. high nuclear /cytoplasmic ratio, prominent nucleoli, 
2. long-term self-renewal or limitless proliferation, 
3. undifferentiated, no specific function as differentiated cells, 
4. specific markers: Oct4, Sox2 and Nanog factors and some surface markers,  
5. normal karyotype, 
6. ability to be subcultured after freezing, thawing, and replating, 
7. colony formation. 
8. high telomerase activity, high alkaline phosphatase activity 
9. pluripotency, the ability to  
    a. form chimeric animals and germ line transmission capacity. Ability to 
contribute to all tissues including germ line after injecting ES cells to a normal 
blastocyst host embryo with different genetic background. 
    b. differentiate spontaneously in cell culture under certain conditions; 
    c. differentiate to form specific cell types under certain conditions;  
d. form teratoma after injecting the ES cells into an immuno-suppressed mouse. 
Teratomas typically contain a mixture of many differentiated or partly differentiated 
cell types—an indication that the embryonic stem cells is capable of differentiating 





1.1.2 Adult stem cells 
Adult stem cell are undifferentiated cells found in a differentiated tissue that can 
renew itself and differentiate to yield all the specialized cell types of the tissue from 
which it originated.  
 Adult stem cells have been identified in many organs and tissues. One important 
point with regrad to adult stem cells is that there are a very small number of stem cells 
in each tissue. Stem cells are thought to reside in a specific area (niche) of each tissue 
where they may remain quiescent (non-dividing) for long periods until they are 
activated by disease or tissue injury. The adult tissues reported to contain stem cells 
include brain, bone marrow, peripheral blood, blood vessels, skeletal muscle, skin and 
liver. The most studied adult stem cells are hematopoietic stem cells (HSCs) and 
mesenchymal stem cells (MSCs). More and more evidence suggests that nanog is 
expressed in some MSCs (see Table 1-1). 
1.1.3 Germ stem cells 
Germ cells are the cells that give rise to the gametes, sperm and eggs, and ensure the 
transmission of genetic information between the generations in sexually reproducing 
organisms. All sexually reproducing organisms are composed of two types of cells: 
the 'mortal' somatic cells, which form the body of the organism, and the 'immortal' 
germ cells, which produce the next generation. During development, precursor germ 
cells (better known as primordial germ cells, PGCs) are created in one part of the 
embryo, often far away from their final destination. They must then migrate to the 
somatic part of the future gonads, where they become mature germ cells — sperm or 
eggs. 
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Typically, PGCs are specified in distinct positions during early embryogenesis 
and actively migrate to the site where the gonad forms. However, germline 
specification differs among groups of animals with two main mechanisms described 
thus far. In mammals and urodele amphibians, germ cell specification is a result of 
induction by somatic cells shortly before and during gastrulation. Consistently, no 
asymmetrically-localized maternally-provided determinants (termed germ plasm) that 
direct cells to be the germline were identified. In the mouse embryo, germ cell 
induction is mediated by secreted factors of the bone morphogenetic protein (BMP) 
family.  In organisms such as Xenopus, zebrafish, Drosophila and Caenorhabditis 
elegans, where inheritance of asymmetrically localized cytoplasmic determinants, the 
germ plasm, is thought to direct cells to the germline lineage (Raz, 2003). 
Germ stem cells (GSCs), which have showed similar pluripotent ability to ES 
cells, have been isolated from mouse and human testis (called SSCs, Conrad et al., 
2008; Guan et al., 2006). Interestingly, Nanog is expressed in male GSCs but not in 








1. 2 Mechanisms modulating pluripotency in stem cells 
1.2.1 Intrinsic transcription factors 
Pluripotency of stem cells is controlled by a variety of transcriptional factors. Besides 
nanog, the best-characterized gene of these is oct4, which functions to maintain 
pluripotency both in vivo and in vitro (Nichols et al., 1998; Niwa et al., 2000). The 
POU homeodomain transcription factor Oct4 (also known as Pou5f1) is expressed in 
all pluripotent cells of the mammals and is down-regulated upon formation of 
extraembryonic and somatic lineages.  Loss of Pou5f1/Oct4 causes inappropriate 
differentiation of the inner cell mass and ES cells into trophectoderm, whereas 
overexpression of Oct4 results in differentiation into primitive endoderm and 
mesoderm, suggesting that precise Oct4 levels are necessary for pluripotency. Oct4 
can regulate gene expression by synergistically interacting with other factors within 
the nucleus, including the high mobility group (HMG)-box transcription factor Sox2. 
Sox2 can act independently (Masui et al., 2007) or synergistically with Oct3/4 in 
vitro to activate Oct-Sox enhancers, which regulate the expression of pluripotent stem 
cell-specific genes, including Nanog, Oct3/4 and Sox2 itself (Boyer et al., 2005; 
Chew et al., 2005; Kuroda et al., 2005; Rodda et al., 2005). Sox2 is necessary for 
regulating multiple transcription factors that affect Oct3/4 expression and maintains 
the requisite level of Oct3/4 expression. However, unlike Oct4, the expression of 
Sox2 is not restricted to pluripotent cells, because Sox2 is also found in early neural 
lineages (Avilion et al., 2003; Ivanova et al., 2006; Masui et al., 2007). 
Sall4 belongs to the Spalt (sal) family, which plays important roles in regulating 
 8
the developmental processes in many organisms. The heterozygous Sall4 knockout 
mice exhibit limb and heart defects. Homozygous Sall4 mutant embryos died before 
E8.0. Sall4 is also known to be expressed predominantly in the ICM of early mouse 
embryos as well as in embryonic carcinoma cells. Immunostaining also revealed the 
presence of Sall4 in the trophectoderm. In adult tissues, Sall4 is predominantly 
expressed in testis and ovary. Sall4 binds to the highly conserved regulatory region of 
the Pou5f1 distal enhancer and activates Pou5f1 expression in vivo and in vitro. Sall4 
can interact with Nanog. This observation is intriguing, as the Sall4 / Nanog complex 
resembles the network configuration for the Oct4 / Sox2 complex (Wu et al., 2006; 
Zhang et al., 2006). In fact, Nanog may have many other partners or cofactors (Wang 
et al., 2006).  
Oct4, Sox2 and Nanog are the earliest-expressed set of genes known to maintain 
pluripotency in vivo and in vitro. They can regulate each other and themselves and 
form a feedforward circuit in ES cells. Recently, Tcf3 and Sall4 were added into this 
circuit (Cole et al., 2008; Lim et al., 2008b). Then these core transcription factors, 
through cooperating with other factors such as Klf4, Esrrb, Smad1, Stat3, Zfp281, 
p300, co-occupy promoters of a lot of target genes to modulate self-renewal or 
















Fig. 1-2 Models of core transcription networks containing Oct4, Sox2 and Nanog. 
Oct4, Sox2, Nanog, Tcf3 and Sall4 can positively regulate themselves and each other 
and form a feed forward circuit to control stem cell pluripotency. They can co-occupy 
promoters of hundreds of target genes. Complex containing Oct4, Sox2, Nanog 
(dimmer form) and others interact with RNA polymerase II complex machinery to 
regulate downstream gene expression. Adapted from Chambers and Tomlinson, 2009; 






1.2.2 Signaling pathways in maintaining ES cell pluripotency: 
1.2.2.1 LIF/Stat3 pathway 
Mouse ES cells were originally derived and maintained on a feeder layer of mouse 
embryonic fibroblasts (MEFs). However, conditioned media from MEFs can support 
the self-renewal of mouse ES cells, eliminating the need for a feeder layer. It was 
subsequently demonstrated that MEFs inhibit ES cell differentiation via production of 
the IL-6 family cytokine, leukemia inhibitory factor (LIF) (Smith et al., 1988; 
Williams et al., 1988). Mouse ES cells can be cultured using recombinant LIF as a 
substitute for MEF feeder cells. The cytokine LIF functions by binding to LIF 
receptor (LIFR) at the cell surface, which causes it to heterodimerize with another 
transmembrane protein, glycoprotein-130 (gp130). This is followed by the activation 
of kinases that amplify and drive the signal to the nucleus. The tyrosine kinase Janus 
kinase (JAK) binds constitutively to the intercellular domain of this receptor complex 
in its inactive form. Upon LIF binding, JAK kinase phosphorylates tyrosine residues 
Y765/812/904/914 of the intracellular domain of gp130 and Y976/996/1023 of LIFR, 
which recruits signal transducers and activators of transcription STAT 1 and STAT3 
through their Src-homology-2 (SH2) domains (Stahl et al., 1995). STAT proteins are 
then activated by JAK-mediated tyrosine phosphorylation to form homodimers and/or 
heterodimers and translocate into the nucleus, where they function as transcription 
factors. STAT3 activation is sufficient for self-renewal in the presence of fetal bovine 
serum (FBS) which contains BMPs (Matsuda et al., 1999; Ying et al., 2003). One of 
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the important target genes of STAT3 is c-Myc (Cartwright et al., 2005). Myc (c-Myc) 
belongs to Myc family of transcription factors, which also includes N-Myc and 
L-Myc genes. Myc-family transcription factors contain the bHLH/LZ (basic 
Helix-Loop-Helix Leucine Zipper) domain. c-Myc regulates expression of 15% of all 
genes, including genes involved in cell division, cell growth, and apoptosis. It exerts 
its effects on transcriptional targets through various mechanisms--there are positive 
effects from recruitment of histone-modifying enzymes, general transcriptional 
machinery, and chromatin-remodeling complexes and negative effects from 
recruitment of DNA methyltransferases. Forced expression of c-Myc eliminates the 
requirement for LIF. Elevated Myc activity is able to block the differentiation of 
multiple cell lineages (Canelles et al., 1997; Knoepfler et al., 2002; Pelengaris et al., 
1999; Schreiner et al., 2001; Selvakumaran et al., 1996). These results suggest 
LIF\Stat3 pathway possibly functions through c-Myc in mES cells. Surprisingly, 
c-Myc behaves quite differently in human embryonic stem cells, where it induces 
apoptosis and differentiation (Sumi et al., 2007). 
 Now it becomes clear that how LIF signals are linked to the core transcription 
factors Nanog, Oct4 and Sox2 (Chen et al., 2008b; Niwa et al., 2009). 
1.2.2.2 Transforming growth factor β (TGF-β) superfamily pathway. 
TGF-β and its family members—the nodals, activins, bone morphogenetic proteins 
(BMPs), Growth and differentiation factors (GDFs ), myostatins, anti-Muellerian 
hormone (AMH), and others—exert profound effects on cell proliferation, division, 
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differentiation, migration, adhesion, organization, and death (Massague, 2008). These 
TGFβ superfamily ligands bind to a type II receptor, which recruits and 
phosphorylates a type I receptor. The type I receptor then phosphorylates 
receptor-regulated SMADs (R-SMADs) which can now bind the coSMAD SMAD4. 
R-SMAD/coSMAD complexes accumulate in the nucleus where they act as 
transcription factors and recruit cofactors and participate in the regulation of target 
gene expression. 
BMPs ligand can bind to heterodimeric complexes of type II (BMPRII, ActRII, 
ActRIIB) and type I (ALK2/ActR-IA, ALK3/BMPR-IA, ALK6/BMPR-IB) receptor 
serine/threonine kinases. Upon BMP binding, R-Smads (Smad1, Smad5, and Smad8) 
are phosphorylated at two C-terminal serine residues pS–x–pS and form heteromeric 
complexes with Smad4.  
TGF β, activins and nodal ligands bind to heterodimeric complexes of type II 
(TβR-II, ActRII, ActRIIB) and type I (ALK5/TGFβ RI, ALK4/Act-IB, ALK7) 
receptor serine/threonine kinases and at last lead to the phosphorylation of R-smads 
(smad2 and smad3) and form heteromeric complex with smad4. 
The intrcellular effectors of TGF β pathway are the Smad transcription factors. 
The name “Smad” was coined with the identification of human Smad1 in reference to 
its sequence similarity to the Sma and Mad proteins in drosophila (Liu et al., 1996). 
Smad proteins are ~500 amino acids in length and consist of two globular domains 
coupled by a linker region. The N-terminal domain, or “Mad-homology 1” (MH1) 
domain, is highly conserved in all Rsmads and Smad4 but not in Ismads (Smads 6 and 
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7). The linker region is quite divergent between the various subgroups, whereas the 
C-terminal or MH2 domain is conserved in all smad proteins (Massague, 2008). The 
MH1 domain is a DNA-binding module stabilized by a tightly bound zinc atom. The 
contact with DNA is primarily established by a β-hairpin structure, which is 
conserved in all the RSmads and Smad4. The Smad MH2 domain is highly conserved 
and is one of the most versatile protein-interacting modules in signal transduction. 
RSmads have a conserved C-terminal motif, Ser–X–Ser, that is phosphorylated by the 
activated receptor. A set of contiguous hydrophobic patches, referred to as the 
“hydrophobic corridor”, on the surface of the MH2 domain mediates interactions with 
cytoplasmic retention proteins, with components of the nuclear pore complex 
(nucleoporins), and with DNA-binding cofactors. A region overlapping the linker and 
MH2 regions (“Smad4 activation domain”, SAD) mediates interactions with 
transcriptional activators and repressors.  
BMP4 (a component in the serum) has been demonstrated to play a role in 
maintaining mouse ES cell pluripotency by induction of Id proteins in the presence of 
LIF (Ying et al., 2003). BMP4 alone facilitated mesodermal differentiation of mouse 
ES cells. LIF alone stimulated neural differentiation of mouse ES cells under serum 
free conditions. However, BMP4 induced expression of inhibitor of differentiation 
(Id), which can prevent neural differentiation of mouse ES cells. Therefore, 
cooperation of LIF and BMP4 make mouse ES cells in an undifferentiated state. 
Human ES cells use a different cytokines in maintaining pluripotency. LIF is not 
required in human ES cells. Self-renewal of human embryonic stem cells (ESCs) is 
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promoted by FGF and TGFβ/Activin signaling, and differentiation is promoted by 
BMP signaling (Beattie et al., 2005; Xiao et al., 2006). BMP4 induces hES 
differentiation into mesoderm and ectoderm (Schuldiner et al., 2000), whereas BMP2 
promotes extraembryonic endoderm differentiation (Schuldiner et al., 2000). 
Repression of BMP signaling in human ES cells plus high doses of bFGF supports 
long term self-renewal in the absence of serum and feeder cells (Xu et al., 2005). 
Recently, Nanog was identified as a direct target of TGFbeta or BMP pathways in 
human ES cells (Xu et al., 2008). Smad2/3 can directly activate Nanog promoter 
where smad1/5/8 repress nanog promoter. The report explained why TGFβ signal is 
required for human ES cell self-renewal where BMPs promote differentiation.  
1.2.2.3 WNT-beta catenin pathyway 
The Wnt/β-catenin signaling pathway has multiple roles in ES cell biology, 
development, and disease (Clevers, 2006; Logan and Nusse, 2004; Reya and Clevers, 
2005). Wnt proteins form a family of highly conserved secreted signaling molecules 
existing from Caenorhabditis elegans to human. The family has 19 members in human. 
Wnt proteins bind to receptors of the Frizzled and LRP families on the cell surface. 
Through several cytoplasmic relay components, the signal is transduced to β-catenin, 
a cytoplasmic protein that functions in cell-cell adhesion by linking cadherins to the 
actin cytoskeleton. It also acts as an intracellular signaling molecule of the canonical 
Wnt signaling pathway. In the absence of wnt activation, β-catenin is in a complex 
with Axin, adenomatous polyposis coli gene (APC), and glycogen synthase kinase 
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GSK3-β and gets phosphorylated and targeted for degradation, thereby keeping the 
level of cytoplasmic β-catenin low. In the presence of wnt signaling, GSK3-β is 
inactivated and β-catenin is dephosphorylated and uncoupled from the degradation 
complex. As a result β-catenin accumulates in the cytoplasm and translocates into the 
nucleus, where it can bind to Lef/Tcf transcription factors and activate targeted genes. 
Over-expression of wnt1 or treatment with lithium chloride, an inhibitor of 
GSK-3β, inhibits neural differentiation (Aubert et al., 2002). ES cells with a mutant 
form of APC show impaired ability to differentiate into the three germ layers 
(Kielman et al., 2002). WNT/β-catenin pathway can prevent ES cell differentiation by 
up regulating Stat3 expression (Hao et al., 2006). Activation of the canonical wnt 
pathway by 6-bromoindirubin-3’-oxime (BIO), a specific pharmacological inhibitor 
of GSK-3, maintain the undifferentiated phenotype in both mouse and human ES cells 
by sustaining expression of Oct4, Nanog and Rex1. Other studies (Ogawa et al., 2006; 
Singla et al., 2006; Takao et al., 2007) also suggested that WNT/β-catenin pathway 
plays a critical role in maintaining ES cells self renewal. However, canonical Wnt 
signaling is required for neural and mesoderm differentiation (Lindsley et al., 2006; 
Otero et al., 2004). These results suggest under different Wnts or culture conditions 
WNT/β-catenin pathway may play different roles. Recently, it was reported ESCs can 
be long-term maintained in serum free media with IQ-1, a small molecule which 
diminishes the β-catenin/p300 interaction and prefer β-catenin/CBP interaction, and 
wnt3a (Miyabayashi et al., 2007). Switch between β-catenin/CBP and β-catenin/p300 
determine the ES cells fate for self renewal or differentiation. The identification of 
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Tcf3 as an integral component of the core regulatory circuitry of ESCs provide some 
clue for the above controversial problem (Cole et al., 2008). Tcf3 is one of the 
terminal components of the canonical Wnt pathway. It can act as a repressor (with 
Groucho) or activator (with β-catenin), determined by binding with different cofactor. 
It can function independent of Wnt pathway or response to Wnt ligands. In ES cells 
under standard conditions, Tcf3 is mainly in repressive complex which is responsible 
for differentiation. Upon activation of Wnt pathway it is mainly in activating complex 
which is responsible for pluripotency (Cole et al., 2008). A balance between the 
repressive complex and activating complex may determine the fate of ES cells. 
1.2.2.4 FGF pathway 
Fibroblast growth factors (FGFs), a large family of polypeptide growth factors found 
in a variety of multicellular organisms, have been implicated in diverse cellular 
processes including apoptosis, cell survival, chemotaxis, cell adhesion, migration, 
differentiation, and proliferation. FGFs play an important role during early vertebtate 
development, especially in induction, patterning of three germ layers and 
morphegenetic movement. In human, FGF protein family consists of 22 members. 
The FGFs are heparin-binding proteins and share a core domain (120 aa) which 
interacts with FGFRs. FGFs (FGF1-10) induce their biological responses by binding 
to and activating FGFRs, a subfamily of cell surface receptor tyrosine kinases (RTKs). 
The vertebrate Fgfr gene family consists of four highly related genes, Fgfr1–4. These 
genes encode for single spanning transmembrane proteins with an extra cellular 
ligand-binding region and an intracellular domain harboring tyrosine kinase activity. 
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Binding of FGFs causes FGFR receptor dimerization and triggers tyrosine kinase 
activation leading to autophosphorylation of the intracellular domain and activation of 
intracellular signaling cascades. During early embryonic development FGF signal 
transduction can proceed via three main pathways: the Ras/MAPK pathway, PI3 
kinase/Akt pathway, and the PLCγ/Ca2+pathway (Bottcher and Niehrs, 2005). 
FGF pathway is required for maintaining pluripotency of human ES cells and 
medaka ES cells, but the mechanisms are still unknown (Vallier et al., 2005). FGF is 
recognized as an evolutionarily conserved neural inducer in ascidians, fish, Xenopus 
and chick (Bottcher and Niehrs, 2005; Wilson and Edlund, 2001). 
Disruption of FGF signaling by Fgfr knock-out or by overexpression of a 
dominant negative FGFR1 strongly affects body axis formation (Amaya et al., 1991; 
Deng et al., 1994; Griffin et al., 1995; Yamaguchi et al., 1994). The phenotypic 
changes are observed mostly in posterior regions, such as defects of trunk and tail 
structures. This is at least partly because of the T-box transcription factor brachyury, 
which is required for posterior mesoderm and axis formation in mouse, zebrafish and 
Xenopus (Conlon et al., 1996; Halpern et al., 1993; Herrmann et al., 1990; Smith et al., 
1991), is downstream of FGF signal (Ciruna and Rossant, 2001; Griffin et al., 1995; 
Griffin et al., 1998; Smith et al., 1991; Strong et al., 2000; Sun et al., 1999; Zhao et al., 
2003). FGFs are involved in a large number of differentiation mechanisms such as 
mesendoderm specification (Burdsal et al., 1998), endoderm differentiation (Wells 
and Melton, 2000), neuroectoderm patterning (Sasai and De Robertis, 1997), and cell 
migration during gastrulation (Sun et al., 1999), FGFs are not usually described as 
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inducers of differentiation but rather appear to act as competence factors for other 
signaling pathways (Cornell and Kimelman, 1994; Cornell et al., 1995). Regulation of 
BMP signal by FGFs may be mediated by the phosphorylation of Smad1 in the linker 
region by MAPK, thus inhibiting Smad1 transcriptional activity (Pera et al., 2003). 
The ability of FGFs to regulate TGFβ/Nodal signaling may be due to phosphorylation 
of Smad2 by MAPKs (Kretzschmar et al., 1999).Therefore, it can be envisaged that 
FGF signaling increases the competency of hESCs and MES1 to receive other signals 
directly involved in pluripotency. No evidence suggests that FGF2 singals are directly 






































1.3 The homeodomain transcription factor Nanog 
1.3.1 General introduction 
The discovery of Nanog, which was named after the mythological Celtic land of the 
ever young, Tír na nÓg, created an era of stem cell research. Since then, many reports 
on the mechanisms of pluripotency have been published. Now it is generally 
described as a pluripotency marker together with Oct4 and Sox2. Nanog is mainly 
expressed in pluripotent cell populations including ES cells, inner cell mass, epiblast, 
primodial germ cells, embryonic germ cells, spermatogonial stem cells (Fig. 1-3).  
1.3.2 Expression pattern 
Nanog expression patterns have been analyzed in pluripotent cells by using northern 
blot and RNA in situ hybridization. In mice, nanog expression is restricted to 
pluripotent cells: inner cell mass, epiblast, primordial germ cells, and ES cells (Fig. 
1-3). Later, more sensitive methods such as immunostaining and RT-PCR were used 
and more expression domains were found in various tissues and some tumors. The 
following is a summary of expression patterns of Nanog in different species. 
Table 1-1 Summary of nanog expression pattern 
Tissues/cell population Technique Reference 
ICM, ES cells, EC cells , EG cells ISH, NB (Chambers et al., 2003; Mitsui 
et al., 2003; Wang et al., 
2003) 
PGCs ISH, IS 
 
(Chambers et al., 2003; 
Yamaguchi et al., 2005); 
Epiblast  ISH, IS (Hart et al., 2004; Yamaguchi 
et al., 2005) 
Germline stem cells (GSCs) IS, RT-PCR (Conrad et al., 2008; Guan et 
al., 2006) 
Adult Testis (human) NB (Clark et al., 2004) 
Fetal ovary (human)  RT-PCR (Clark et al., 2004) 
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Gonocyte of fetal teistis (human) IS (Hart et al., 2005) 
MSC (human) IS (Gonzalez et al., 2007; Guillot 
et al., 2007) 
Neural crest cells, neural tube (human) ISH (Thomas et al., 2008) 
Adult bone marrow (human);  EST clone; NB  (Hart et al., 2004; Yan et al., 
2005)  
Epiblast, anterior neural plate, neural tube, 
mesonephros tubeles, germ cells (chicken) 
ISH (Lavial et al., 2007) 
Carcinoma in situ (CIS) ISH (Almstrup et al., 2004) 
CIS, embryonal 
carcinoma, and seminoma 
IS (Hart et al., 2005) 
Testis, seminoma, breast cancer RT-PCR, IS (Ezeh et al., 2005) 
Breast cancers Microarray (Ben-Porath et al., 2008) 
Ovarian germ cell tumours (OGCTs) IS (Hoei-Hansen et al., 2007) 
Primary central nervous system, germ cell 
tumours 
IS (Iczkowski and Butler, 2006) 










1.3.3 Nanog target genes 
Considering Nanog’s central role in maintaining cell pluripotency, there must be a lot 
of target genes. In hESCs, Nanog can associate promoter regions of 1554 genes 
(Boyer et al., 2005) and co-occupy at least 353 genes together with Oct4 and sox2 
(chip-chip data). In mESCs, Nanog can bind to promoter regions of 434 genes (Loh et 
al., 2006). However, only 92 genes are the same between human and mouse ES cells. 
This suggests that although hESCs and mESCs cells share a common core 
transcription factor network, they are still distinct from each other at least in the 
aspect of mechanisms. Actually, only 32 common genes are co-occupied by Oct4 and 
Nanog in mES and hES cells. These genes include Nanog, Sox2, REST, Zic3, Tcf3, 
Eomes, Sall1 and Rif1.  
Nanog binds to its target genes via its unique homeodomain. Current lines of 
evidence suggest that Nanog binds to promoter regions through a core element CATT 
(or AATG) (Jauch et al., 2008; Loh et al., 2006; Mitsui et al., 2003). However, thus 
far only a few genes have been demonstrated to be direct targets by luciferase (LUC) 
reporter assay and/or Electrophoretic mobility shift assay (EMSA). These target genes 
include pou5f1 (TAATGG, GAATGT), sox2 (GAATGG, GAATGC), nanog 
(GAATGT, GAATAG), tcf3 (TAATGG), esrrb (TAATGA), gata6 (TAATCA), rex1 
(GAAT), cdx2 (TAAT) (Jauch et al., 2008; Loh et al., 2006; Shi et al., 2006; Singh et 
al., 2007; Wang et al., 2008a). Among these binding motifs, ‘TAATGG’ has the 
highest affinity with Nanog HD domain (Jauch et al., 2008; Loh et al., 2008). 
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1.3.4 Regulation of nanog 
Nanog is not the only pluripotency-associated gene. Cell pluripotency is maintained 
by several critical intracellular factors and extracellular cytokines. Nanog regulates 
many targets genes and at the same time, it is regulated by other factors. Any change 
of Nanog mRNA and protein level may change the ES cell state. Therefore, the 
regulation of Nanog should be a basic problem of understanding pluripotency. 
Positive regulation by Oct4, Sox2 and Nanog itself has been discovered (Boyer et al., 
2005; Loh et al., 2006; Rodda et al., 2005). Oct4 recognizes an 8-bp DNA site with 
the consensus ATGCAAAT (ATTTGCAT). Sox2 binds to the consensus 
A(T)A(T)CAAAG. Usually Oct4 and Sox2 bind DNA cooperatively to the 
non-parlindromic cognate sequences always occur adjacent to one another in a 
particular relative orientation. In mouse nanog proximal promoter the Oct4-Sox2 
binding sequence is TTTTGCAT-TACAATG. Activation of Wnt pathway by 
6-bromoindirubin-3'-oxime (BIO) also up-regulates Nanog (Sato et al., 2004). The 
effect may be mediated by Tcf factors (Cole et al., 2008). GCNF and P53 are negative 
regulators of Nanog (Gu et al., 2005b; Lin et al., 2005). Sall4 can positively regulate 
nanog promoter (Wu et al., 2006). Tcf3 can function as repressor or activator to 
regulate Nanog by cooperating with different cofactors (Cole et al., 2008; Pereira et 
al., 2006; Tam et al., 2008; Yi et al., 2008). Other regulation factors include: Tpt1 
(Koziol et al., 2007), Foxd3 (Liu and Labosky, 2008; Pan et al., 2006), Stat3 (Suzuki 
et al., 2006), Brachyury/T (Suzuki et al., 2006), Zfp143 (Chen et al., 2008a),  Klf5 
(Ema et al., 2008; Jiang et al., 2008; Parisi et al., 2008), Klfs (Klf2, Klf4 and Klf5) 
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(Jiang et al., 2008), LRH1 (mediated by Oct4, possiblely by direct regulation) (Gu et 
al., 2005a), Zfp206 (Wang et al., 2007), Zfp281 (Wang et al., 2008c), Sp1/Sp3 (Wu 
and Yao, 2006), Pbx1 (Chan et al., 2009). Nanog is also directly regulated by Smads 
(positive effect by TGF-β/Activin/nodal signal via Smad2/3; negative effect by BMPs 
via samd1/5/8), explaining why hESCs need the activation of TGFβ pathway (Vallier 
et al., 2009; Xu et al., 2008). In addition, nanog can be regulated by microRNA at the 
post-transcriptional level (Tay et al., 2008a; Tay et al., 2008b). In posttranslational 
level Nanog can be negatively regulated by Caspase. ES cells lacking Casp3 gene 
showed marked defects in differentiation, while forced expression of a caspase 
cleavage-resistant Nanog mutant in ESCs strongly promoted self renewal (Fujita et al., 
2008).The following figure shows the nanog 5-kb promoter is occupied by some 

















Fig. 1-4 Regulation of nanog by other transcription factors. Nanog is regulated by 
many other transcription factors and itself. The factors in the drawing are not all the 
factors that regulate nanog. The nanog proximal promoter contains Oct4-Sox2 
binding sites. Distal enhancer contains Klfs and Stat3 binding sites. Tcf3, GCNF and 











1.3.5 Cofactors of Nanog 
As a transcription factor, Nanog exerts its function by homo-dimerization or as a 
monomer (Mullin et al., 2008; Wang et al., 2008a). Nanog–Nanog homodimers 
(through WR subdomain) constitute a major fraction of Nanog protein complexes in 
ES cells. Furthermore, Nanog forms multiple protein complexes with apparent sizes 
of ~150kDa to several mega-Daltons (Wang et al., 2006). These data suggest Nanog 
functions with many partners. To date we know that Nanog can interact with Oct4, 
Sall4, Nac1, Zfp281, Zfp198, Dax1, REST, Sp1 and others (Wang et al., 2006; Zhang 
et al., 2007). Besides, Nanog can also bind to other important effectors in ES cells or 
tumor cells: Stat3 (Bourguignon et al., 2008), Smad1/2/3 (Suzuki et al., 2006; Vallier 
et al., 2009) and NF-kappaB (Torres and Watt, 2008). It is suggested that Nanog, Oct4, 
Sox2, Smad1, Stat3 and p300 form a core cluster to regulate many target genes (Chen 
et al., 2008b). Besides these transcription factors, Nanog and Oct4 can associate with 
unique transcriptional repression complexes including NuRD, Sin3A and Pml in ES 
cells (Liang et al., 2008). Whether Nanog functions with these partners in vivo is still 
unknown.  
1.3.6 iPS –induced pluripotent stem cells by defined factors 
Previously, reprogramming differentiated somatic cells into a pluripotent state can be 
achieved by somatic cell nuclear transfer (SCNT) (Wilmut et al., 1997). However, the 
efficiency and feasibility is largely compromised, especially for human. Recently a 
new method called iPS technique emerged. In 2006, Takahashi and Yamanaka 
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reported that mouse embryonic fibroblasts (MEFs) and adult tail tip fibroblasts could 
be reprogrammed back to a pluripotent state by introducing four transcription factors 
Oct4, Sox2, Klf4 and c-Myc via retroviral delivery coupled to reactivation of a 
neomycin-resistant reporter gene under the endogenous control of Fbx15 (Takahashi 
and Yamanaka, 2006). The iPS cells exhibit some features characteristic of ES cells: 
they are positive for alkaline phosphatase (AP), express the ES cell-specific surface 
marker SSEA-1, express Nanog from the endogenous locus, differentiate into all three 
germ layers in vitro, and form teratomas when injected into immunodeficient mice. 
This a milestone event in stem cell field, albeit that these iPS cells are not genuine 
pluripotent for the reason that chimeric embryos arrested in mid-gestation stage when 
iPS cells were injected into blastocysts. Improved methods selecting reactivation of 
Oct4 or Nanog locus but not Fbx15 at last got the germ-line competent iPS (Meissner 
et al., 2007; Okita et al., 2007; Wernig et al., 2007). Germ-line transmission is 
considered to be one of the most stringent criteria to evaluate pluripotency. The four- 
factor method was soon extended to human and exhibited its general practicability 
(Park et al., 2008; Takahashi et al., 2007). However, one drawback of this method is 
that these iPS cells can contribute not only three germ layer but also tumor at a high 
efficiency by the reactivation of c-myc transgene (Okita et al., 2007). For the 
four-factor composition, Nanog is not required for the initial steps but reactivation of 
endogenous expression is required. To avoid the tumorigenic effect of c-myc, Yu et al 
screened ten genes in human and found a new composition: Oct4, Sox2, Nanog and 
Lin28 (Yu et al., 2007). Both methods absolutely require Oct and Sox2. Nanog is only 
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required for the second method. Considering the first method still requires the 
reactivation of Nanog locus, critical roles of Nanog in maintaining and establishing 
pluripotency are underscored by iPS techniques.  
1.3.7 Domain structure of Nanog protein  
Nanog is a homeoprotein which contains a unique homeodomain and is different from 
all other known homeobox protein families, including the most similar NK2 family 
and vent family. The sequence YKQVKTWFQN appears to be diagnostic of Nanog 
homologues (Fig. 1-5). Nanog homologues from mouse and human are composed of 
four exons and span approximately 7kb on chromosome 6 or 13, respectively. The 
murine nanog cDNA consists of 2184 nucleotides (nt) and contains a single open 
reading frame encoding a polypeptide of 305 amino acids. The cDNA also has a long 
3’ untranslated region of 1077 nt containing a B2 repetitive element with unknown 
function (Mitsui et al., 2003). 
Nanog protein contains three domains: N-terminal domain (ND), middle 
homeodomian (HD) and C-terminal domain (CD). CD domain can be subdivided into 
CD1, WR and CD2 domains. WR is the region that contains ten WXXX (W is 
Tryptophan while X is any aa) repeats in mouse and eight in human (Fig. 1-6). WR 
domain is required for homodimerization and protein-protein interaction (Wang et al., 
2008a). ND contains a smad4 homolog domain and is rich in serine. Both the ND and 
CD have the trans-activation ability, where the HD is mainly required for interaction 
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with the DNA. HD mediating protein-protein interaction was also reported (Wu et al., 
















Fig. 1-5 Alignment analyses of homeodomains from various homeoproteins. 
Nanog contains a unique sequence “YKQVKTWFQN’ (boxed with red color) among 
all known homeobox family proteins. Hs, Homo sapiens; Mm, Mus musculus; Rn, 
















The expression pattern of nanog was discussed before. Its main expression domain is 
in ES cells, EC cells, EG cells, PGCs, GSC cells, pre-implantation ICM, 
post-implantation epiblast from E4.5 to E8, fetal and adult testis, fetal ovary and 
human neural crest cells. All of them are related to cell pluripotency. 
Fig. 1-6 Nanog domain structure. Underlined region is homeodomain and boxed 
region is WR domain. Nanog has 10 WXXX repeats in mouse homolog but only eight 
in human homolog. Human NANOG lacks the 4th and 10th repeats comparing to 





1.4 Medaka as a vertebrate model 
1.4.1 General introduction 
Medaka is a small, egg-laying freshwater fish native to Asia that is found primarily in 
Japan, Korea and eastern China. In Japanese medaka means a tiny fish with big eyes. 
The medaka provides a good model for analyzing vertebrate development. This fish 
offers a unique opportunity to combine embryological, genetic and molecular 
analyses of early vertebrate development. It is one of the smallest vertebrates (3 cm in 
length) and easy to maintain and has a short generation time (2-3 months). Its 
spawning can be controlled by artificial light cycle. It daily produces numerous eggs 
all year round. The eggs are large (1 mm in diameter), transparent and convenient to 
manipulate. Fertilization occurs externally. Embryogenesis takes about 10 days. The 
medaka genome draft almost has been completed. It has a diploid chromosome 
number of 48 with estimated genome of 800 Mb. It is only half that of zebrafish, 
another popular model in studying vertebrate development. Furthermore, several 
medaka stem cell lines have been established (Hong et al., 2004a; Hong et al., 2004b; 
Hong et al., 1996) and provide another good in vitro model to study mechanisms of 
stemness.  
As a vertebrate model, medaka fish has many strains. The following strains are 
kept in our lab: HB32C (brown or black); Hd-rR (White and Orange-Red Strain, used 
in the medaka genome project; i-1, a complete albino phenotype with mutation in 
tyrosinase gene; i-3: albino strain with mutation in oca2 encoding a tyrosine 
transporter.  
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Fish is the most successful vertebrates in the world because it has more than 
22,000 species. There are several fish models used in research. Zebrafish (Danio rerio) 
and medaka (Oryzias latipes) are mainly used in developmental biology and genetics. 
Japanese pufferfish fugu (Fugu rubripes) and Green spotted pufferfish (Tetraodon 
nigroviridis) are models for genome research. Platy (Xiphophorus maculates) is a 
model used in cancer research. Different models have their own advantages and 
usually provide respective useful information. To compare the information from 
different fishes we need to know their relationship in evolution. The divergence time 
between medaka and Fugu is about 100 myr (million years). To our surprise, 
zebrafish is a far relative of medaka in that their divergence time is about 140-200 
myr (Fig. 1-7). That is to say, the two developmental models are much more different. 
This difference rationalizes the existence of two fish models in developmental biology. 
When we compare the genes or phenotypes we must notice this point—fishes are not 
always the same when comparing to other vertebrates.  
A very interesting phenomenon is the whole genome duplication happened in 
ancestor of teleosts. The duplication led to about 30% genes in fish genome with more 


















Fig. 1-7 Phylogeny of vertebrates. The divergence time between fish (ray fins) and 
mammals (from lobe fins) is about 450 myr. Medaka is a close relative of fugu and 









1.4.2 Stem cell research in medaka 
ES cells provide a promising tool for the generation of transgenic animals with 
site-directed mutations. When ES cells colonize germ cells in chimeras, transgenic 
animals with modified phenotypes are generated and used either for functional 
genomics studies or for improving productivity in commercial settings. So far he ES 
cell approach has been limited to mice; there is strong interest for developing the 
technology in other animals such as fish.  
In 1994, Wakamatsu et al. adopted the feeder layer technique and reported the 
first medaka ES-like cell line OLES1 (Wakamatsu et al., 1994). Later in 1996, Hong 
et al developed a feeder-free culture system, in which blastula-derived stem cells are 
cultured on gelatin-coated substrata. One of medaka ES cell lines, MES1, has been 
characterized as pluripotent in vitro, including stable growth, normal karyotype, and 
the ability to differentiate into functional cell types of the three germ layers. 
Following transplantation to the host blastulae, MES1 cells participate in chimeric 
development. This cell line displays pluripotency specific gene expression, as shown 
by the ability to activate the mouse Oct4 regulatory elements (Hong et al., 2004b).  
1.4.3 Medaka embryonic development  
The medaka embryos develop to the hatching stage within 10 days at 26℃. The 
mature unfertilized egg is opaque and soft. It is an oblate spheroid with an average 
1.25mm in horizontal diameter and 1.17mm in vertical diameter. Once stimulated by 
a spermatozoon arriving at the vitelline surface through the micropyle, cytoplasmic 
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free calcium increase and at last a fertilized egg is produced through a series of 
reactions. From zygote to fry there are many different stages which can be classified 
as follows: Zygote period: 60 minutes (min); Cleavage Period: 2 -32 cells, 1h5min to 
3h30min; Morula Period: 64-512 cells, 4h5 min to 5h15 min; Blastula Period: from 
1000 cells, 6h30 min to 8 h15 min,; Gastrula Period: 10h20 min -21h; Neurula Period: 
1 day1h-1 day2 h, head formation, optic bud formation; Segmentation Period: 1day 
3h-4day5h, formation of somites; Pharyngula period: 4-8 days; Hatching Period: 9 - 
10 days. 
1.5 Zebrafish as a vertebrate model 
1.5.1 Zebrafish as a popular vertebrate model 
Zebrafish, a small tropical fresh-water fish (teleost) which lives in rivers of northern 
India, northern Pakistan, Nepal, and Bhutan in South Asia, has become a powerful 
vertebrate model for various biological studies. The great advantages of zebrafish as a 
model are rapid ex-utero development, high fecundity and optical clarity of the 
embryos which allow straightforward observation and various manipulations during 
early developmental stages. Currently there are several vertebrate models for studying 
developmental biology, namely, mouse, chicken, Xenopus, zebrafish and medaka. In 
zebrafish, the time for finishing gastrulation, becoming motile fry and growing to 
adult is 10 hour, 3 days and 3 months, respectively. It has the fastest speed among 
these models. Except for the classic gene knockout technique used successfully in 
mouse, all other major genetic tools including ENU induced mutant analysis, gain of 
function by DNA or mRNA injection or electroporation, knock down by antisense 
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Morpholino oligo and transgenic approach can be applied in zebrafish. In addition, 
zebrafish genes were demonstrated on average greater than 75% similarity to human 
genes. Therefore, zebrafish offer a powerful combination of low cost, rapid in vivo 
analysis by various genetic tools and complex vertebrate biology. During late 
development zebrafish has some differences with mammals, but the very early 
development is extremely similar among vertebrates. For vertebrate axis formation, 
zebrafish is a well established model (Schier and Talbot, 2005).  
 
1.5.2 Early Stages of embryonic development of zebrafish 
Zebrafish embryo develops from a zygote to a movable larva just within two days. Its 
embryogenesis can be divided into seven consecutive periods: zygote period (0-0.75 
h); cleavage period (0.75-2.25 h); blastula period (2.25-5.25 h); gastrula period 
(5.3-10 h); segmentation period (10-24 h); pharyngula period (24-48 h) and hatching 
period (48-72 h). Upon fertilization, cytoplasmic streaming generates a large 
blastodisc on top of the yolk. During the following 3 h of development, rapid, 
synchronous cleavage divisions occur within the blastodisc to generate a blastula 
embryo consisting of ∼1000 cells, initially arranged in a pile (blastoderm) atop the 
yolk. During cleavage, the volume of the embryo remains essentially constant, so that 
the divisions produce a larger number of smaller cells. The cells in the blastoderm 
form the embryo proper, whereas the yolk is an extraembryonic structure. Cell cycles 
lengthen and become asynchronous during the mid-blastula transition (MBT). The 
MBT begins at the 512-cell stage (2.75 hpf), when cell division has increased the 
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nuclear: cytoplasmic ratio to a critical threshold. The MBT also marks the onset of 
bulk zygotic transcription, so that the zygotic genome begins to govern embryonic 
development. Also around the time of the MBT, cells at the blastoderm margin 
collapse into the yolk and form the yolk syncytial layer (YSL), a thin, multinucleate 
structure at the interface of the blastoderm and the yolk. At the time of MBT, the 
zebrafish embryo is composed of three distinct cell layers: the enveloping layer (EVL), 
deep cells, and the yolk syncytial layer (formed from the fusion of cells adjacent to 
the yolk cells). The first stage of gastrulation begins with the epiboly of the EVL and 
the deep cells over the YSL. This epiboly is driven by the migration of nuclei and 
cytoplasm in the YSL and attachments between the YSL and the EVL. Intercalation 
of the deep cells with the EVL helps drive this movement. In the process of epiboly, 
cells intercalate radially, thereby thinning the blastoderm and spreading over the yolk. 
By the end of gastrulation, epiboly movements have spread the blastomeres so that the 
blastoderm covers the entire yolk cell; the extent of yolk cell coverage (measured as 
“percent epiboly”) provides a convenient way to determine an embryo’s 
developmental stage. Three other movements (internalization, convergence and 
extension) contribute to the formation of the axis. Beginning at 5 hpf, cells at the 
margin internalize (move toward the yolk and back toward the animal pole) and form 
the so-called hypoblast, the precursors of the mesoderm and endoderm (this usage of 
the term hypoblast is different from that in mouse and chick, where it denotes 
extraembryonic tissue). The upper layer onto the hypoblast is epiblast (embryonic 
ectoderm). The epiblast and hypoblast contribute to the formation of embryo proper. 
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By 6 hpf (about 60% epiboly), convergence and extension movements have begun, 
resulting in the dorsal accumulation of cells moving from lateral and ventral regions 
of the blastoderm (convergence). Concomitantly, converging cells intercalate with 
dorsal blastomeres, spreading them along the animal-vegetal axis, leading to a 
lengthening of the anterior-posterior axis (extension). Convergence of cells toward the 
dorsal side of the embryo marks the first clearly apparent break in radial symmetry 
and forms shield, a thickening at the dorsal blastoderm margin that is the teleost 
equivalent of the amphibian Spemann-Mangold organizer (SMO). During later 
gastrulation (about 75% epiboly), the axial hypoblast (presumable prechordal plate) 
becomes clearly distinct from the paraxial hypoblast (presumable somites and their 
derivatives in the trunk and muscles and endothelium in the head). The dorsal epiblast 
begins to thicken towards the end of gastrulation and make the beginning of 
development of neural plate. At the end of gastrulation, the embryo has the vertebrate 
body plan consisting of the anterior-posterior axis (segmented vertebral column and 
skull) and the dorso-ventral axis (including the ventrally located mouth). In 24 hours, 
an organized embryo is generated with a head, notochord, and mesodermal somites 





















Fig. 1-8 Zebrafish fate maps (From Schier and Talbot, 2005) 
(a) Fate map at 50% epiboly stage, the onset of gastrulation. Lateral view, dorsal to 
the right, animal pole to the top. Germ layers are arranged along the animal-vegetal 
axis. Different mesodermal and ectodermal fates are arranged along the dorsal-ventral 
axis. No precise boundaries are depicted because cell fates are often intermingled.  
(b) Fate map of ectoderm at 90% epiboly. Lateral view, dorsal to the right, animal 
pole and anterior to the top.  
(c) Model fate map of mesoderm at early somite stage.  
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1.5.3 Molecular vertebrate axis formation in zebrafish 
During the early developmental stages of vertebrate, three distinct asymmetries, 
namely, animal-vegetal (AV) polarity, dorsoventral (DV) and anteroposterior (AP) 
body axes are established. Axis formation depends largely on maternal and zygotic 
genes and involves a series of inductive cell interactions. In the fly, frog and zebrafish, 
an animal-vegetal (AV) polarity emerges upon localization of maternal components, 
including transcripts, proteins, cytoskeleton or mitochondria, to distinct cytoplasmic 
parts of the egg (Cheng and Bjerknes, 1989; Gard et al., 1997; Howley and Ho, 2000; 
Rand and Yisraeli, 2001; Reim and Brand, 2006; Volodina et al., 2003). Cells are 
endowed with different sets of these determinants and acquire their fates according to 
their position. In zebrafish AV-asymmetry probably prefigures DV polarity and AP 
body axes.  
Dorsoventral (DV) patterning is initiated by maternal factors and subsequently 
refined zygotically (Heasman, 2006; Schier and Talbot, 2005; Wang and Dey, 2006). 
In frog and fish, localized zygotic domains are induced whereby cells either express 
dorsal or ventral genes (Heasman, 2006; Schier and Talbot, 2005). In detail, DV 
patterning in vertebrates integrates: (1) dorsalizing pathways involving dorsal 
stabilization of maternal β-catenin (Kelly et al., 2000; Schier, 2001; Wodarz and 
Nusse, 1998); (2) ventralizing pathways depending on maternal and zygotic TGFβ 
signaling (Bauer et al., 2001; Goutel et al., 2000; Hammerschmidt and Mullins, 2002; 
Kishimoto et al., 1997; Mintzer et al., 2001; Schmid et al., 2000; Sidi et al., 2003), 
Vent homeodomian family (Gilardelli et al., 2004; Imai et al., 2001; Kawahara et al., 
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2000; Shimizu et al., 2002) and zygotic Wnt signaling (Ramel and Lekven, 2004); and 
(3) noncanonical Wnt/Ca2+ signaling, which downregulates canonical Wnt signaling 
(Pandur et al., 2002). In the zebrafish embryo, β-catenin accumulates specifically in 
nuclei of dorsal margin blastomeres as early as the 128-cell and induce the dorsal axis 
(Dougan et al., 2003; Schneider et al., 1996). This asymmetric nuclear localization of 
β-catenin is an early marker of the dorsoventral axis (Fig. 1-9). Soon after the 
mid-blastula transition, β-catenin activates the expression of a number of zygotic 
genes, including bozozok, chordin, dickkopf1 (dkk1), squint (sqt) and FGF signals 
(Schier and Talbot, 2005). These β-catenin targets act to inhibit the action of 
ventralizing factors. Meanwhile, other maternal factors activate the major ventralizing 
genes (bmp2b, bmp4 and bmp7), and the vent family (vox, vent and ved) of 
transcriptional repressors of dorsal genes (Schier and Talbot, 2005). Zebrafish 
embryos lacking BMP2b (swirl), BMP7 (snailhouse), Vox and Vent (in the TL strain) 
or Vox, Vent and Ved (in the AB strain) activity are severely dorsalized, with 
expanded trunk somitic fates, reduced blood, vasculature, and pronephros fates, and 
loss of tail tissue (Dick et al., 2000; Flores et al., 2008; Imai et al., 2001; Kishimoto et 
al., 1997; Nguyen et al., 1998; Reim and Brand, 2006; Schmid et al., 2000; Shimizu et 
al., 2002). To date, maternal Pou2, TGF-β protein Radar, Smad5 and Runx2 have 
been identified to induce zygotic bmp2b, bmp4, ved, vent (Flores et al., 2008; Kramer 
et al., 2002; Reim and Brand, 2006; Sidi et al., 2003). Among these maternal factors, 
Pou2 (homolog of mammalian Oct4) is required to activate zygotic bmp2b and bmp4. 































Fig. 1-9 Transcriptional interactions patterning the dorsal-ventral axis. Lateral 
view, dorsal to the right, animal pole to the top. (a) β-catenin is stabilized on the 
dorsal side during cleavage stages. Soon after mid-blastula transition, vox is expressed 
ubiquitously. (b) β-catenin activates bozozok (boz), which represses vox, vent, and ved 












1.6 Objetives of this study 
Medaka ES cells (MES1) have been isolated for more than ten years (Hong et al., 
1996), however, it is not well characterized on the molecular level thus far. To 
identify the marker genes of MES1, we chose the mammalian nanog gene, which is 
representative of pluripotency in vitro and in vivo, as our target. By systematic 
analysis of the fish homologues, we hope we can identify the pluripotency genes in 
lower vertebrates such as medaka and zebrafish. 
Nanog is required for epiblast formation. The pioneer study (Mitsui et al., 2003) 
demonstrated that nanog null embryo only formed extraembryonic endoderm at E5.5, 
which indicates that nanog is required for preventing ICM cells differentiation toward 
extraembryonic endoderm lineage. Recently, nanog null ESCs have been reported to 
still possess pluripotency, but compromised proliferation and proneness to 
differentiation (Chambers et al., 2007). These studies underscore the roles of nanog in 
maintaining pluripotency in vivo but not in vitro. This raises a question as to whether 
nanog is a real pluripotency player, like Oct4. Studies in lower vertbrates such as fish 
may provide useful information.  
The absolute requirement for Nanog in the earliest stages of developing embryos, 
namely epiblast formation, limits experimental analyses of Nanog in subsequent 
stages of mammal development. Expression in pre-implantation ICM is to establish 
the plutipotent state and prevent differentiation. In fact, Nanog expression sustains in 
posterior epiblast from post-implantation to the end of gastrulation (Hart et al., 2004; 
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Thomas et al., 2008). Whether Nanog plays similar roles in these tissues has not been 
addressed. 
So far, nanog has been extensively studied in the mouse and human. However, the 
fact that Nanog has undergone salient sequence divergence raises a question as to 
whether this gene would have evolved functional divergence in diverse vertebrates. 
Lower vertebrates such as laboratory fish models medaka (Oryzias latipes) and 
zebrafish (Danio rerio) are excellent systems for molecular analyses of early 
embryonic development (see introduction). In particular, genes essential for 
pluripotency and/or patterning can been analyzed easily in detail in medaka (Thermes 
et al., 2006) and zebrafish (Reim and Brand, 2006). By systematic analysis of the 
pluripotency gene nanog in fish models we hope we would find some new insights 









Chapter II: Materials and Methods 
2.1 DNA manipulation 
2.1.1 Polymerase chain reaction (PCR)  
Standard PCR was performed in a 25 µl reaction using PTC-100TM peltier thermal 
cycler (Biorad, USA), Geneamp PCR system 9700 (Applied Biosystems, USA) and 
Mastercycler gradient (Eppendorf, Germany). Each reaction included 2.5 μl 10×PCR 
buffer (0.2 mM Tris-HCl, pH 8.8, 0.1 M KCl, 0.1 M (NH4)2SO4, 20 mM MgSO4, 
1% (v/v) Triton X-100), 1 μl of 5 mM dNTP mix, 1 μl of 10 μmol sense primer, 1 μl 
of 10 μmol antisense primer, 1 μl template, 0.2 μl 5U/µl Taq polymerase. The 
parameters for standard PCR consist of first denaturation at 94°C for 3 minutes, 
following 35 cycles of amplication process including denaturation at 94°C for 20 
seconds, annealing at 55°C for 30 seconds and extension at 72°C for 1 minute and 
final extension at 72°C for 10 minutes. 
2.1.2 Reverse-transcriptase PCR (RT-PCR) 
RT-PCR was performed by two step reaction. First step involved synthesis of first 
strand cDNA and second step involved amplification of fragments of interest from 
single strand cDNA as template. First strand cDNA was synthesized from total RNA. 
A typical reaction was performed in 25 μl total volume containing 5 μl 5× first strand 
buffer (250 mM Tris-HCl, pH 8.3, 375 mM KC, 15 mM MgCl2, 50 mM DTT), 1.25 
μl 10 mM dNTP, 1 µl RNAse inhibitor (40 U/µl, N251A, Promega, USA), 1 µl oligo 
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dT primer (1 µg/µl), 2 µg total RNA and 1 µl MMLV reverse transcriptase (200U/µl, 
M170B, Promega, USA). Total RNA and oligo dT primer should be pre-mixed, 
heated to 70°C and cooled on ice before adding the other components to prevent 
secondary structure within the template. After incubation at 42°C for 1 hour, the 
cDNA temple was heated at 70 °C for 5 minutes. After dilution, the cDNA was ready 
for use or stored at -80°C. 
2.1.3 Rapid amplification of cDNA ends (RACE) 
RACE was applied to obtain the full length of a given gene fragment. A kit from BD 
Biosciences Clontech (USA) was used. To get both ends of the gene, 5’ RACE ready 
cDNA was prepared using 5’-CDS primer (5'–(T)25V N–3', N = A, C, G, or T; V = A, 
G, or C) and BD smart II A oligo (AAGCAGTGGTATCAACGCAGAGTACGCGGG) 
and 3’ RACE ready cDNA were prepared using 3’-CDS primer 
(AAGCAGTGGTATCAACGCAGAGTAC(T)30VN'). SMART represents Switching 
Mechanism At 5' end of RNA Transcript. The BD PowerScript Reverse Transcriptase 
can add several dC residues when reach the end of the mRNA template. So the BD 
SMART II A Oligo (with three continuous dG) anneals to the tail of the cDNA (with 
three continuous dC) and serves as an extended template for BD PowerScript RT. 
When PCR was applied to amplify the 5’ or 3’ ends of cDNA, a gene specific primer 
(GSP) and Universal Primer A Mix (UPM) containing long UPM  
CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT and 
short UPM CTAATACGACTCACTATAGGGC were needed. The long UPM 
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contains part of CDS primer sequence and the whole sequence of short UPM. The 
parameters for RACE touchdown PCR were as followed: 5 cycles of (94°C 30 sec, 
72°C 2 min), 10 cycles of (94°C 30 sec, 70°C down to 61°C by each cycle 30 sec, 
72°C 2 min), 22 cycles of (94°C 30 sec, 65°C 30 sec, 72°C 2 min) and a final 
extension at 72 °C 10 min. 
2.1.4 Cloning of PCR products (T-A cloning) 
To clone the products into plasmid, the pGEM-T easy vector (Promega, USA) was 
used. The linearized vector contains two 3’ T overhangs at the insertion site. The PCR 
products contains two 3’ A overhangs generated by Taq polymerase. Under the help 
of T4 ligase, the PCR products and the vector can be ligated easily to form a circular 
plasmid for transformation, sequencing or subsequent sub-cloning.  
2.1.5 DNA ligation 
Normally, DNA ligation reaction was performed in 20 µl of volume containing 4μl 
5×ligation buffer (250 mM Tris-HCl, pH 7.6, 50 mM MgCl2, 5 mM ATP, 5 mM DTT 
and 25% (w/v) polyethylene glycol-8000), insert DNA, vector DNA (20ng -200ng ) 
and 1 µl T4 ligase (Invitrogen). The molar ratio of insert: vector DNA was usually 3:1. 
Ligation mixture was incubated overnight at 16°C for sticky end or 4°C for blunt end. 
2.1.6 Preparation of competent cells  
Good competent cells are critical for cloning. Normally an efficiency of ~108 
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transformed colonies per µg supercoiled plasmid is satisfactory for most cloning 
requirement. The bacteria strain TOP 10 F’ (Invitrogen) was used for preparation of 
competent cells. Two milliliter of LB broth was incubated with a single fresh colony 
at 37°C with 200 rpm shaking overnight. In the following morning, 1 ml of overnight 
culture was inoculated into 100 ml LB with 20mg MgSO4 and shaken at 200 rpm at 
37°C until OD600 reached 0.4-0.6 (about 3 hours). The culture was chilled on ice for 
15 minutes and centrifuged at 2,500 g for 15 minutes at 4°C. The cell pellets were 
resuspended in 40 ml Tfb1 (100 mM RbCl, 30 mM Potassium acetate, 50 mM MnCl2, 
10 mM CaCl2 and 15% glycerol, pH 5.8). After incubation on ice for 15 minutes, the 
cells were spun down and resuspended in 4 ml TfbII (10 mM MOPS, 10 mM RbCl, 
75 mM CaCl2 and 15% glycerol, pH 6.5). After incubation on ice for 20 minutes, the 
competent cells were transferred into 1.5ml EP tubes in 100μl aliquot, fast-frozen in 
liquid nitrogen and stored at -80°C. During the preparation of competent cells, two 
points should be noted. Resuspending the pellet cells was done very gently. After first 
centrifugation, the cells should be kept below 4°C during the following process.  
2.1.7 Transformation 
Usually 5-10 μl ligation mixture was added into the freshly thawed competent cells 
and incubated on ice for 30 minutes. For plasmid transformation this incubation step 
was omitted. Following incubation, the mixture was heated to 42°C for 60 seconds in 
a water bath and cooled immediately on ice for 2 minutes. After adding 400μl LB 
medium, the heat shocked mixture was shaken at 200 rpm in a 37°C incubator for 1 
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hour and 150 µl mixture was spread onto LB agar plate (for A-T cloning the plate also 
containing pre-spread 10 µl 1M IPTG and 30 μl 50 mg/ml X-gal) supplemented with 
ampicillin or kanamycin. The plate was left at room temperature for 10 minutes and 
incubated at 37°C by invertedly placement. 
2.1.8 Colony screening by restricion enzyme digestion 
Although PCR screening was commonly used to screen the colony, screening by RE 
digestion was preferred. Usually 10 colonies were selected and amplified in 3ml LB 
medium with appropriate antibiotics. Plasmid was extracted using alkaline lysis 
method described section 2.1.10 in this chapter and digested with appropriate REs to 
identify the correct clones. 
2.1.9 Automatic sequencing 
Each sequencing reaction (5 μl) consists of 2 µl Bigdye mix, 1 μl 50~100 ng double 
strand DNA, 1 μl primer (3.2 pmol/µl) and 1 µl water. The single primer extention 
was done in a PCR machine with 25 cycles of 96°C for 10 seconds, 52°C for 5 
seconds and 60°C for 2 minutes. After adding 0.5 μl 3 M NaOAc (pH 4.6) and 12.5µl 
95% ethanol, the reaction products were incubated on ice for 30 minutes and 
centrifugated at 4°C for 20 minutes at 16,000 rpm. The pellet was washed with 500µl 
of 70% ethanol twice, air dried, desolved in Hi-Di and sequenced by the automatic 
sequencer (ABI 3100A, Applied Biosystems). 
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2.1.10 Isolation of plasmid DNA 
Small scale preparation of plasmid DNA was carried out by Kit from Qiagen (USA). 
The protocol involved several steps including alkaline lysis, binding of plasmid DNA 
to a silica-based resin and elution in low salt buffer or water. Normally, about 10 µg 
of high copy number plasmid DNA can be isolated from 3-5 ml of overnight (12-16 
hr) bacterial culture in Luria-Bertani (LB) medium with appropriate antibiotics. Here, 
a simple cost effective method was used in my normal cloning. 
Overnight bacteria cultures grown in LB (pH7.4) with 100 µg ampicilin or 50 µg 
kanamycin were poured into 1.7 ml eppendorf (EP) tube and spun down at 8000 rpm 
in a table centrifuge machine (Eppendorf 5417C, Germany) for 2 minutes. The pellet 
was resuspended in 100µl solution I (15 mM Tris-HCl, 10 mM EDTA, 100µg/ml 
Rnase A) by votex. 100µl freshly prepared Solution II (immediately mixed with equal 
volume of 2% SDS and 0.4 M NaOH) was added to the bacterial suspension and 
mixed by gently inverting the tubes four times. This mixture was neutralized by 
adding 100 μl solution III (3 M KAC-HAC, pH 5.5), followed by addition of 60 µl 
chloroform. After being centrifuged at 14,000 rpm for 10 minutes, 200 ul clear 
supernatant was transferred to a new EP tube and mixed with 500ul ethanol, then 
re-centrifuged at 14, 000rpm for 15 minutes at 4°C. The DNA pellet was drained by 
careful aspiration of residual ethanol or air dry and eluted with 30μl Mili-Q water or 
10 mM Tris-HCl (pH 8.0).  
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For cell transfection or microinjection, midi-prep or maxi-prep (Qiagen, Novagen 
or Macherey-Nagel) was performed according to the manufacturer’s manual. For low 
copy number plasmid preparation, midi-prep was preferred.  
2.1.11 Isolation of genomic DNA 
A standard protocol for genomic DNA isolation described by Sambrook et al (1989) 
was followed. The protocol consists of digestion of tissue with proteinase K, DNA 
extraction with phenol and precipitation with ethanol. First, an adult medaka (~300 
mg) or zebrafish (500 mg) was quickly frozen in liquid nitrogen and ground into fine 
power using a mortar and pestle. 10 ml of extraction buffer (10 mM Tris-HCl, 100 
mM EDTA, 20 µg/ml pancreatic RNAse and 0.5% SDS, pH 8.0) was added into the 
power and incubated at 37°C for 1 hour. Then proteinase K was added to a final 
concentration of 100 µg/ml and incubated at 50°C for 3-5 hours with gentle shaking. 
The viscous solution was extracted two times with equal volume of phenol (pH 7.9) 
and one time with 1:1 phenol and chloroform. The aqueous phase was mixed with 0.1 
volume 3 M NaOAc and 2.5 volume of ethanol and the genomic DNA floccules will 
appear in the solution. The DNA floccules were collected by swirling with a glass rod 
and washed by 70% ethanol. After 5 minutes air-dry, the DNA was dissolved in 500ul 
TE buffer (10mM Tris-HCl, pH 8.0, 1mM EDTA) and stored at 4°C. The quantity 
and quality of genomic DNA were determined by gel electrophoresis and 
nano-photometer (Kisker-biotech, Germany). 
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2.1.12 Purification of DNA fragments from agarose gel 
Gel extraction kit (Qiagen, USA or Macherey-Nagel, Germany) was used for 
recovering DNA fragments ranging from 100 bp to 10 kb from agarose gel according 
to manufacturer’s instructions. The procedure consists of melt of gel containing DNA 
of interest, binding of DNA to the column, washing and elution.  
2.1.13 Purification of DNA from enzyme reaction solution 
Commercial kits (Qiagen, USA or Macherey-Nagel, Germany) were used for DNA 
recovery from enzyme reaction solution. The procedure is similar to gel extraction 
kits with omitting the gel melt step. Sometimes the following method was preferred. 
After reaction (PCR, RE digestion etc.), DNA was extracted by equal volume 
of 1:1 phenol: chloroform, precipitated by adding 2.5 volume of ethanol, incubation at 
-20°C for 30 minutes and centrifugation at 15,000 rpm for 15 minutes at 4°C. The 
pellet was then air-dried and dissolved in proper volume of water or TE buffer. 
2.1.14 Restriction endonuclease (RE) digestion of DNA 
RE digestion was employed to screen recombinant clones or to get interest of DNA 
fragment for following cloning. The REs used in this study were purchased from 
Promega, New England Biolabs or Fermentas. Normally, digestions were performed 
at 37°C for 1 hour to 4 hours or overnight according to activity of different enzymes 
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with recommended buffers. For a given reaction, the maximum DNA concentration 
was 300 ng/µl and 5-10 units of enzyme were used to digest 1 µg (plasmid) DNA. 
2.1.15 DNA gel electrophoresis 
DNA electrophoresis was performed in 1% agarose gel for DNA size larger than 1 kb 
and 2% gel for size smaller than 1kb. The agarose power was dissolved in 1×TAE 
(0.04 M Tris-base, 0.02 M acetic acid, 0.01 M EDTA, pH 8.0; usually prepare 50X 
for stock) by microwave heating. The melted gel was kept in 60°C oven avoiding of 
solidification. For gel casting, the melted gel was poured into an appropriate tray and 
a few drops of ethidium bromide (EB) were added to a final concentration of 
0.5μg/ml with thorough mixing. A voltage of 5 V/cm was applied. 
2.1.16 Quantification of DNA by spectrophotometry 
DNA quantity was examined by the nano-photometer (Kisker-biotech, Germany) 
using only 1-2μl in volume. 
2.1.17 Bioinformatic analysis 
The DNA or protein sequence was analysed with Bioedit (Ibis Biosciences), 
DNAMAN (Lynnon Biosoft) and Vector NTI software (Invitrogen). Online sequence 




2.1.18 Vectors  
pGEM T easy (Promega) was used for general cloning. pCS2+ was used for mRNA 
and probe synthesis. pET32a (+) was used for protein expression (Novagen). pCVpr 
and pCVpf were used for cell transfection. Major vectors are listed in the appendix. 
2.2 RNA manipulation 
2.2.1 Isolation of total RNA 
Total RNAs were extracted from embryos and different adult tissues using TRIzol 
regent (Invitrogen, USA). Tissue samples (less than 100 mg) were homogenized in 1 
ml TRIzol regent in 1.5ml EP tube with a pestle on ice. The following procedures 
were performed according to manufacturer’s instructions. Especially, during 
transferring the upper aqueous phase, the interphase should not be touched to avoid 
DNA contamination. 
2.2.2 Synthesis of 5’ capped mRNA 
The cDNAs for synthetic RNA were cloned into pCS2+ vector (Rupp et al., 1994). 
The plasmid was linearized by Not1 and purified by phenol: chloroform extraction 
and ETOH precipitation to get template for mRNA synthesis using mMESSAGE 
mMACHINE Kit (Ambion, USA). Normally, a routine synthesis of 15 μg of 7-methyl 
guanosine capped RNA was achieved from 0.5 μg of template DNA with Sp6 
bacterial promoters, in a 10 μl volume, during a 2 hour reaction. The amount and the 
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quality of the obtained RNAs were estimated by gel electrophoresis and 
nano-photometry. 
2.2.3 Quantification of RNA by spectrophotometry 
RNA was measured by a nano-photometer (Kisker-biotech, Germany) with a volume 
of 1-2μl. 
2.2.4 In situ hybridization 
2.2.4.1 Probe synthesis 
Normally 10 µg of plasmid with cDNA insertion in pCS2+ or pGEM T easy was 
completely linearized by a suitable enzyme (blunt or 5’ overhang should be preferred 
to avoid snap back effects) to get anti-sense or sense probe. Linearized template was 
purified by phenol:chloroform extraction and ETOH (ethanol) precipitation. The 
synthesis reaction was performed at 37°C for 2 hours in a total volume of 20 µl 
containing 4 μl of 5×transcription buffer, 2 μl of 10 mM NTP mix with 
Dig-UTP/Fluorescein-UTP (Roche), 1 μg of template DNA, 0.5 μl of RNase inhibitor 
(40 U/µl) (Promega) and 1 μl of T7 (Sp6) polymerase. Following the reaction, 1 μl of 
Turbo DNase (Ambion, USA) was added to digest the DNA template at 37°C for 15 
minutes. After the digestion the RNA probe was precipitated by adding 30 μl RNase- 
free water and 30 μl Lithium Chloride Precipitation Solution (7.5 M lithium chloride, 
50 mM EDTA, pH 8.0), washed with 70% ethanol, air-dried and dissolved in 25 μl 
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DEPC-treated water. At last the probe was quantified, diluted to a final concentration 
of 1 ng/µl in hybridization buffer and examined by normal agarose gel running. 
2.2.4.2 Whole mount in situ hybridization (WISH) 
Staged medaka embryos were fixed in 4 % PFA (paraformamide)/0.85×PTW (prepare 
16% PFA as stock) for 48 hours at 4°C , washed three times with PBS and stored in 
50% formamide/2× SSC (pH 6.5) at -20°C. After dechorionization, the embryos were 
transferred into 100% methanol and stored in -20°C for at least one overnight. When 
hybridization was started, the embryos were transferred into 24 or 48 well cell culture 
dish and rehydrated gradually through 75% MeOH (methanol)/PTW (0.1% tween in 
0.85×PBS), 50% MeOH/PTW, 25% MeOH/PTW and PTW (three times). Following 
rehydration, the embryos were digested by Proteinase K (PTK) (10 μg/ml in PTW, 
prepare 20 mg/ml for stock) (Roche, Germany) at room temperature for following 
probe penetration. Embryos younger than 1 day (before neurula stage) were not 
necessary for PTK treatment. Embryos from 1 day to 3 days were treated for 3-15 
minutes. Embryos older than 3 days were treated for 15-30 minutes. As an alternative 
method, embryos can be heat treated in a 96°C water bath for 5-30 minutes to break 
down some cross link bonds by PFA fixation. After PTK digestion, the embryos were 
rinsed twice in freshly prepared 2 mg/ml glycine/PTW, re-fixed in 4% PFA/PTW for 
20 minutes and washed 5 times in PTW. For prehybridization, the embryos were 
rinsed in hybridization buffer (50% formamide (Sigma), 5xSSC, 50 μg/ml heparin, 
0.1%Tween20, 5 mg/ml torula RNA, pH 6.0-6.5) and incubated at 68°C for 2 hours. 
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The probe was diluted in 200 μl hybridization buffer to a final concentration of 1-5 
ng/µl and denatured at 80°C, followed by 2 minutes of ice water bath. Then the 
prehybridization buffer was removed and the ready probe was added. Hybrizization 
was performed at 68°C in a waterbath for 16 hours with snow shaking. In the second 
day, the posthybridization embryos were washed in 50% formamide/2xSSCT (diluted 
from 20×SSC, pH 7.0, 0.1 % Tween) at 68°C for 1 hour with one time solution 
change, 2xSSCT at 68°C for 30 minutes and 0.2xSSCT at 68°C for 1.5 hours. After 
hybridization, RNase free condition is not required. Subsequently, the embryos were 
washed twice with PTW at room temperature and blocked with 5% sheep serum/PTW 
at room temperature for 1 hour on a snow shaker. Then the blocking solution was 
removed and the embryos were incubated with anti-Dig-AP Fab fragments (Roche) at 
a 1: 2500 dilution in 5% sheep serum/PTW at room temperature or alternatively 
incubated overnight at 4°C. Following antibody incubation, the embryos were washed 
in PTW six times for 15 minutes each and washed again in TBST (100 mM TrisCl, pH 
9.5, 100 mM NaCl, 0.1%Tween-20) twice for 2 minutes each. Then the embryos were 
equilibrated for 5 minutes in staining buffer NTMT (100 mM TrisCl, pH 9.5, 100 mM 
NaCl, 50 mM MgCl2, 0.1%Tween20, prepared freshly) and incubated with NTMT 
containing BCIP (final 175μg/ml, stock: 50 mg/ml in 100% DMF) and NBT (final 
337.5μg/ml, stock: 75 mg/ml in 70% DMF/H2O) in darkness without shaking at 4°C 
from several hours to days until signals coming out. The staining process was stopped 
by washing three times with PTW. For immediately photography, the embryos were 
deyolked if necessary and rinsed in 87% glycerol overnight for picture taken. 
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Photographed embryos were stored in 2% PFA in darkness. 
For ovary WISH, the outer layer membrane was removed after fixation for probe 
penetration. For testis WISH, the accurate PTK treatment was necessary. 
2.2.4.3 Section in situ hybridization (SISH)  
To tell apart which cell types expressing the genes of interest, detailed cross section 
was required. After fixation, the tissues or embryos were dehydrated by rinsing in 
20% sucrose/PBS overnight, 30% sucrose/PBS for 2 hours, 1:1 of 30% sucrose: 
O.C.T (embedding medium) for 30 minutes and embedded in O.C.T with liquid 
nitrogen in a special mould under stereomicroscope. Embedded tissues or embryos 
were kept below -20°C and fixed to a supporting base for cryostat (CM1850, Leica, 
USA). Section was done at 4 um for testis, 8 um for ovary and 6 um for other tissues. 
The sections were collected onto pre-cleaned slides (Fisher scientific, USA) and 
stored at -80°C. For hybridization, the sections were baked on a 42°C heating block 
for 30 minutes and directly rinsed in hybridization buffer. The following steps were 
similar to WISH. 
2.2.4.4 Fluorescent in situ hybridization 
To detect low abundance mRNA expression in embryos or tissues, tyramide tignal 
amplification (TSA) method was applied to increase the detection sensitivity up to 
100-fold, as compared with conventional ISH with chemical substrates such as 
BCIP/NBT detection. The TSA method utilizes the catalytic activity of horseradish 
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peroxidase (HRP) to generate high-density labeling of a target nucleic acid sequence 
in situ through a mechanism that the highly reactive, short-lived tyramide radicals 
covalently couple to amino acid residues (principally the phenol moiety of protein 
tyrosine residues) in the vicinity of the HRP–target interaction site with minimal 
diffusion-related loss of signal localization. Briefly, after post hybridization wash 
(from the last wash Tween 20 was omitted) the hybridized embryos were blocked and 
incubated with anti-fluorescein POD for 4 hours at room temperature followed by six 
washes for 20 minutes each with PBS. These embryos were then incubated in TSA 
plus fluorescein solution for 60 minutes followed by rinsed orderly in 30%, 50%, 75% 
and 100% methanol/PBS for 5 minutes each and then changed to 1% H2O2 in 100% 
methanol with an incubation of 30 minutes. Following this incubation, these embryos 
were rinsed orderly in 75%, 50% and 30% methanol/PBS and washed three times 
with PBS for 10 minutes each. For second probe detection, the embryos were blocked 
and incubated with anti-DIG POD for 4 hours at room temperature followed by six 
washes for 20 minutes each with PBS. These embryos were then incubated in TSA 
plus Cy3 solution for 60 minutes followed by three washes for 10 minutes each with 
PBST. Finally, the embryos were deyolked, stained with DAPI and mounted with 
anti-fade reagent for photography. 
2.3 Protein manipulation 
2.3.1 His-tagged fusion protein expression and purification 
A single recombinant colony (BL21 as host) was picked and inoculated into 4 ml LB 
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containing the appropriate antibiotic (Ampicilin) and grow overnight at 30°C until the 
OD600 reached 1. The 4 ml overnight culture was inoculated into 400 ml LB with 200 
µg/ml ampicilin and incubated in a 37 °C shaker at 200 rpm until OD600 reaches 0.6. 
Then IPTG was added to the culture to a final concentration of 1 mM to induce the 
fusion protein expression. The induction process sustained 3-6 hours until 
recombinant protein reached the highest yield. The cells were harvested by 
centrifugation at 4000g for 20 minutes, drained completely as possible and stored at 
-20°C. For protein purification, the RoboPop™ Ni-NTA HisBind purification kit was 
used according to the manufacturer’s instructions (Novagen). 
2.3.2 Antibody preparation 
The SPF (specific pathogen free) rat was chosen as host animal. Approximately 200 
μg purified protein was emulsified in complete Freund Adjuvant (Sigma) and 
subcutaneously injected into rat. Every two weeks the rats were subcutaneously 
booster-immunized with the same amount of the protein emulsified in incomplete 
Freund Adjuvant. Six weeks later, the antiserum was collected and stored in aliquot at 
–20°C until used. 
2.3.3 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed using Bio-Rad Mini-PROTEAN 3 cell. Standard 10% 
separating gel and 5 % stacking gel were prepared according to molecular handbook 
(Sambrook and Russell, 2001). Samples were then mixed with 2×SDS-gel loading 
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buffer (50 mM Tris-HCl pH 6.8, 4% SDS, 0.02% bromophenol blue, 20% glycerol, 
100 mM DTT and boiled for 5 minutes before loading into the wells. Electrophoresis 
was carried out in 1×gel running buffer (25 mM Tris, pH 8.3, 192 mM glycine, 0.1% 
SDS (w/v)) at a constant voltage of 60 volts. After electrophoresis, the gel was stained 
in 50 ml Ponceau S staining solution.  
2.3.4 Western Blot 
After electrophoresis, proteins were transferred to a PVDF (Bio-rad) membrane in 
transfer buffer (25 mM Tris, 192 mM glycine, 0.037% SDS, 20% methanol) using a 
semi-dry electroblotter at 18 V for 30 minutes. The PVDF membrane was blocked in 
5% non-fat milk/TBST (50 mM Tris, pH7.4, 150 mM NaCl, 0.1% Tween-20) for 1 h 
with shaking. Following blocking, the membrane was briefly rinsed with TBST and 
incubated with primary antibody (1:500 dilution) for 2 h at room temperature or 
overnight at 4°C followed by four washes with TBST for minutes each at room 
temperature. Then the membrane was incubated with secondary antibody (anti-rat IgG 
peroxidase conjugate, A5795, Sigma) diluted at 1:100,000 with 5% non-fat 
milk/TBST for 1 hour followed by four washes with TBST. Finally, the membrane 
was incubated with the mixture of ECL detection reagents (Pierce, USA) for 2 
minutes in darkness. Signal was detected using Fuji film to expose at 10 seconds, 3 




2.3.5 Immunohistochemical staining 
Cultured cells was fixed in 4% formaldehyde in PBS for 20 min at room temperature 
and rinsed three times with PBS for 10 minutes each, followed by permeabilization 
with 0.2% Triton X-100 in PBS for 6 minutes. For sections this step was omitted. 
After rinse with PBST three times, the slides with cells or sections were blocked with 
10% goat serum in PBST for 30 minutes. Following blocking, the slides were 
incubated with primary antibody (1:100) for 1 hour at room temperature or overnight 
at 4°C in a humidified chamber. After four washes with PBST for 10 minutes each, 
the slides were incubated with secondary antibody (FITC or Texas Red conjugated) at 
a dilution of 1:100 for 1 hour in darkness at room temperature, followed by another 
four washes for 10 minutes each. Finally, the slides was incubated with 1 µg/ml DAPI 
or PI for 5 minutes and mounted with antifade reagent (Invitrogen). 
 
2.4 Culture of medaka ES cells 
2.4.1 Preparation of medaka embryo extract  
Embryos were collected, separated by rolling with two needles, and incubated in a 10 
cm bacterial logical petri dish containing ERM (NaCl 1.00 g, KCl 0.03 g, 
CaCl2 ·2H2O 0.04 g, MgSO4·7H2O 0.16 g, Methylene blue 0.0001 g, final volume 
1000 ml) at 26°C with medium replacement every day. Dead embryos stained with 
blue color were removed to prevent subsequent mold contamination. On the 7th day, 
embryos were collected, drained and stored at -20°C. When embryos were up to 
10,000, they were melted and homogenized on ice. The homogenates were diluted 
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with PBS to a final concentration of 400 embryos/ml, fast frozen in liquid nitrogen 
and thawed at 37°C with three cycles and spun at 18,000 rpm at 4°C for 30 min. The 
upper lipid layer was removed and the homogenates were re-centrifuged until lipid 
layer was invisible. Then the clear supernatant was transferred to EP tubes in 1ml 
aliquot and stored at -20°C.  
2.4.2 Preparation of fish serum 
Fish serum has mitogenic roles in culturing medaka ES cells. Fish serum from 
rainbow trout (Oncorhynchus mykiss), common carp (Cyprinus carpio) and seabass 
(Lates calcarifer) has been used successfully in our lab. Fish blood was collected 
from tail vein by a 10-ml syringe with trace of anti-coagulation (heparin or EDTA) 
and spun at 4°C for 30 min at 4,000 rpm. Then the upper clear supernatant was stored 
at -20°C in 1 ml aliquot until used.  
2.4.3. Preparation of tissue culture plate  
Culture dish or plates for medaka ES cells should be pre-coated with gelatin (Sigma). 
Briefly, 0.1% gelatin solution was autoclaved, filtrated through 0.22 um filter, added 
into the dishes or plates and incubated at room temperature for 1 h. Then the gelatin 
solution was aspirated followed by air-drying for at least 2 hours. 
2.4.4 Preparation of ES cell medium ESM4 
The standard culture medium for medaka ES cells was ESM4, which consists of 
DMEM 13.4 g/l (Gibico), 20 mM Hepes (sigma), 15% FBS (Gibico), 1×penicillin and 
streptomycin (Invitrogen), 2 nM L- glutamine (Invitrogen), 1x Non-essential amino 
acids (Invitrogen), 1× Na pyruvate (Invitrogen), 100 µM 2-mercaptoethanol (Sigma), 
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2 nM Na selenite (Sigma), 0.2% sebass serum, 10 ng/ml bFGF, 0.4 embryo/ml 
medaka embryo extract (MEE), final pH 7.5. 
2.4.5 Subculture of ES cells  
Medaka ES cells were cultured in a feeder free condition and subculture was very 
convenient. Briefly, ES cells grown in one well of 6-well plate were rinsed three times 
with PBS to remove the residual medium and incubated with 1×Trypsin-EDTA 
(Invitrogen) for 3-5 minutes. Then Trypsin-EDTA solution was aspirated and 2 ml of 
ES medium was added to one well. ES cells were re-suspended by pipetting up and 
down several times and split by 1:3 to other wells or plates. 
2.4.6 Counting Cells  
Cell suspension was prepared by trypsination and dropped into the chamber of the 
hemacytometer (Sigma). Cell counting was done according to the instructions. 
2.4.7 Freezing of ES cells 
ES cells were trypsined, resuspended in ESM4 and mixed with equal volume of 
pre-cooled 2×freezing medium (35%FBS, 20% DMSO, 45% DMEM). The cells were 
aliquoted into 2-ml cryovials, kept on ice for 30 minutes and frozen gradually to -80 
°C with a freezing box containing isopropanol. On the second day, these frozen cells 
were transferred to -150°C cell bank freezer for long-term storage.  
2.4.8 Thawing of ES cells 
Thawing of cells should be done as quickly as possible. Cells in cryovials were 
thawed in a 37°C water bath for less than 1 minute and spun briefly at 300g. The 
freezing medium was removed and fresh ESM4 was added into the cryovial. After 
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being resuspended, the cells were transferred to 6-well plate and incubated at 28°C.  
2.4.9 Cell Transfection with GeneJuice  
Cell transfection was performed using Genejuice kit (Novagen) according to the 
manufacturer’s instructions. Normally, cells were grown to 50-80% confluence before 
transfection. For a well of a 6-well plate, 100 μl DMEM (serum free) and 8 μl 
GeneJuice were pre-mixed for 5 minutes and mixed with 2 μg DNA for another 10 
minutes and then added to the cells by drop-wise. After incubation for 6 hours, the 
medium was replaced with fresh ESM4 medium and cultured for 36 hours. 
2. 5 Microinjection into cytoplasm of medaka embryos 
The chorion of medaka embryos is very hard and not easy to be penetrated by glass 
capillary needles. And because the barrier between cytoplasm and yolk are not penetrable 
for oligos, the injection was done in the cytoplasm not in the yolk. Medaka 
microinjection needs much patience. Briefly, DNA, RNA or Morpholino oligo solution 
with phenol red was loaded in a glass capillary needle pulled with a Micropipette Puller 
P-87 (Sutter Instrument, USA). The capillary needle was then loaded to a self-made 
micro-injector using mineral oil as pressure transmitter. The tip of the capillary needle 
was broken by slightly touched with a forceps under microscope and the red injection 
solution should come out when pressure was given. Then the needle was ready for 
microinjection into the cytoplasm of 1-cell stage embryos which were separated by 
rolling with two needles and arranged in the agarose grooves (1mm width and 1mm depth) 
rinsed in 1x Yamamoto Ringer’s solution (NaCl 7.5 g, KCl 0.2 g, CaCl2 · 2H2O 0.2 g, 
NaHCO3 0.02 g, final volume 1000 ml, pH 7.3, usually diluted from 10× stock). 
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Normally, 0.5 nl or 1 nl was injected into the cytoplasm of one-cell or two-cell embryos. 
















Chapter III: Characterization, expression and function of medaka nanog  
3.1 Results 
3.1.1 Isolation of a nanog homolog from medaka 
Nanog has a characteristic homeobox domain (HD) with a unique motif 
YKQVKTWFQN. Outside this HD, low sequence conservation exists even between 
chicken and mammal Nanog homologues (see appendix 1). Cross-species 
comparisons by using the human Nanog query in the NCBI database led to the 
identification of a putative tetraodon (Tetraodon nigroviridis) Nanog protein of 384 
amino acids (aa; CAF93536). Since the tetraodon is a close relative of medaka, this 
putative protein was used as a query to blast against the medaka genome draft, 
resulting in the identification of several scaffolds encoding putative HD-containing 
proteins. One of them, scaffold119 (DF069318) predicts a partial protein containing 
the unique motif (see below). RT-PCR analysis revealed that this fragment was 
specifically transcribed in gonads (Fig. 3-1). By 5’ and 3’ RACEs we obtained a 
cDNA from a morula cDNA library, termed Ong for medaka nanog gene, which is 
1655 nucleotides (nt) in size. Ong has a 1263-nt open reading frame encoding 420 
amino acids, as well as contains a 109-nt 5’ untranslated region (UTR) and a 273-nt 3’ 
UTR containing a putative polyadenylation signal 14 nt upstream a polyA tail, and 
thus represents a full length cDNA (Fig. 3-2). Ong contains a homeodomain with the 
unique motif YKQVKTWFQN (Fig. 3-2. 3-3). While this study was carried out, a 
1263-nt cDNA sequence (only CDS sequence) for a putative medaka nanog became 
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available (NP_001153902), which is 98% identical to our Ong cDNA clone in both nt 
and aa sequence.  
3.1.2 Gene structure of Ong 
Comparison of cDNA to medaka genome indicates that Ong has four exons, E1, E2, 
E3, and E4 with size of 494, 371, 144 and 619 bp, respectively (Fig. 3-4). 
Interestingly, the conserved homeodomian spans exon 2 and exon 3 and the boundary 
just lie in the sequence encoding ‘YKQVKTWFQN’ with ‘YKQ’ in exon 2 and 
‘VKTWFQN’ in exon 3 (Fig. 3-4). This kind of gene structure appears in all nanog 
homologs but not Nkx2.5 and vent members. Nanog is most resembling Nkx2.5 and 
vent homeobox transcription factors among all homeobox proteins. However, all 
current known members of Nkx2.5 and vent family contain less than four exons (Fig. 
3-4) and have distinct binding motifs on target genes’ promoter (Jauch et al., 2008), 
further indicating nanog is not a member of Nkx2 or vent family. Ong protein 
contains a homeodomain of 60 amino acids located between aa 209 and 268, but does 
not have the WXXX repeats in the C-terminus that is characteristic of the higher 
mammalian Nanog (Fig. 3-5).  The WXXX repeats were originally considered as a 
diagnostic character of nanog protein. Whereas, neither chicken nor platypus (lower 
mammals) nanog has the WXXX repeats, suggesting the appearance of the repeat is a 














Fig. 3-1 PCR cloning of the Ong cDNA. (A) RT-PCR cloning of a partial cDNA 
fragment (CDS region, 1.3kb). L, liver; T, testis; O, ovary; M, 100 bp maker; N, 
negative control; G, genomic control. (B) 5’-RACE. (C) 3’-RACE. DNA size 








Fig. 3-2 Ong gene nucleotides sequence and its deduced anmino acid sequence. 
The Ong cDNA consists of 1655 nucleotides and contains an open reading frame 
encoding a polypeptide of 420 amino acids. The Ong gene has four exons that are 
alternatively highlighted in grey color. Exon and intron boundaries are indicated with 
vertical arrowheads. The 5’ and 3’ primers for RACE are boxed and indicated with 
arrows. The homeodomain amino acid sequence is bolded. Putative ployadenylation 
signal sequence is bolded in the last second line.  
1    GAGGTACAATGTTACAATTGTTCACGTTTATTTCTTCTCAATGCATTTTTAAGTAACTTGAGATTTTACGGTTTTGAGAAGACGGTTTCC 
                          3’RACE primer 
91   CCTTTTTAGTAAAAAAAAAATGGCGGAGTGGAAAACTCAGGTCAACTACAACCCCACATTCCATGCGTACACCTATGGCTTCGTGTATCA 
                         M  A  E  W  K  T  Q  V  N  Y  N  P  T  F  H  A  Y  T  Y  G  F  V  Y  Q  
181  AACTGGGCCCGAACAGAACCACGTTACCGGGAACGACTGGAGCCAAAACTGTGAGCAGAACGGCTACAACGGAGGACCCACGCAGTCTCA 
       T  G  P  E  Q  N  H  V  T  G  N  D  W  S  Q  N  C  E  Q  N  G  Y  N  G  G  P  T  Q  S  H  
271  TTTCCCAGCTAGGAGCCGGGAGGAGTCCCCACCTCGCAGCCCGGAGCAGCAGCCTGAGAGCGGCCACTATTACCAGGACTCCGGGGTGGT 
       F  P  A  R  S  R  E  E  S  P  P  R  S  P  E  Q  Q  P  E  S  G  H  Y  Y  Q  D  S  G  V  V  
361  ATACATCAGAGAAGCCCAGACGGGCCGCTTGGTTATGGCGGGACAGCACCGGGTCGGTTTAGACGGCGGCGAAAACTGCACGAGACGGAC 
       Y  I  R  E  A  Q  T  G  R  L  V  M  A  G  Q  H  R  V  G  L  D  G  G  E  N  C  T  R  R  T  
451  CGGAAGCGATTCTGCCAGCGACTCCGAGGCACACACATCACCGGATTCTTGGAGTTCATGCAGCAACTATGAAAGAAGTGTTCCTCAGAC 
       G  S  D  S  A  S  D  S  E  A  H  T  S  P  D  S  W  S  S  C  S  N  Y  E  R  S  V  P  Q  T  
541  AGATCCTGTAGTTTGGGTCAAAAATGAAGAGCAGACTGGAGCAAGGAGCCCAGACCACAGCGAGGATGTCTCCAGCTCGCTCATGGTTGA 
       D  P  V  V  W  V  K  N  E  E  Q  T  G  A  R  S  P  D  H  S  E  D  V  S  S  S  L  M  V  E  
631  GTCCCAATCTTTTGCAGTCCAAGACACCGGGGATGCAAGCAGTTCCACACATGCACCCTTCACCAACACAAAGAAGCAAGCCAGCAGTAC 
       S  Q  S  F  A  V  Q  D  T  G  D  A  S  S  S  T  H  A  P  F  T  N  T  K  K  Q  A  S  S  T  
721  TCCAAACGCCCCGAAAGCTAAGGTCCGGGCAGCTTTCTCTGAGAGCCAGATGAGCACTCTGTTGCAGCGCTTCAGCGTGCAGAGGTACCT 
       P  N  A  P  K  A  K  V  R  A  A  F  S  E  S  Q  M  S  T  L  L  Q  R  F  S  V  Q  R  Y  L  
                                                                              5’RACE primer 
811  CACCCCAGCTGAGATGAAGAACCTGGCAGATGTGACTGGACTCACCTACAAGCAAGTGAAAACATGGTTTCAGAACCGTAGGATGAAGCT 
       T  P  A  E  M  K  N  L  A  D  V  T  G  L  T  Y  K  Q  V  K  T  W  F  Q  N  R  R  M  K  L  
901  TAGGAGGCATCAGAAGGACACCAGCTGGGTTTCAGAGCGATATACAATCAACAAGGACAACACGGCTGCTGACACTGTATTCTCAAACGT 
       R  R  H  Q  K  D  T  S  W  V  S  E  R  Y  T  I  N  K  D  N  T  A  A  D  T  V  F  S  N  V  
991  GGCTCCACATGTCCCCCCTTATCAGGGGGATGGGATGTCCCATCTGCGGCATCACTACAACCAGCACATGATGGGGGCAGCTTTCAAGAA 
       A  P  H  V  P  P  Y  Q  G  D  G  M  S  H  L  R  H  H  Y  N  Q  H  M  M  G  A  A  F  K  N  
1081 TACCCCACACAACCTGGCCTTCTATCTGGCTGCCATGGGTAACCCCCCTGGAACTGCTGGTTACCCGCCATGGTCTTCCAGCCCCCCCCA 
       T  P  H  N  L  A  F  Y  L  A  A  M  G  N  P  P  G  T  A  G  Y  P  P  W  S  S  S  P  P  Q  
1171 GGCTGCGGTGCCCAGCAGACCCCAGGTACCAGGATGGCCCCTGCCGCCAGGCCGCAGTCAGTTTGAATTCTGCCCAATTCCATACGACTC 
       A  A  V  P  S  R  P  Q  V  P  G  W  P  L  P  P  G  R  S  Q  F  E  F  C  P  I  P  Y  D  S  
1261 CTCCGACGCCGCCTCTTTAAACAACTTTGAGCGCAACGCAGTCCCCGACAGCAAAGATGGGGAGTCTGCTGGGGGTGCGAATGCAGCCAT 
       S  D  A  A  S  L  N  N  F  E  R  N  A  V  P  D  S  K  D  G  E  S  A  G  G  A  N  A  A  I  
1351 TTTGCACAATGCTGTCCAATGAGGTAGACAGCAACTGTTGTTCAGTTCAGCATTTTTTGTTGACCGTTTTTCCACTGGATGGGTGTACAA 






Fig. 3-3 Alignment of homeodomain aa sequences of Nanogs from different 
animal species. The unique sequence ‘YKQVKTWFQN’ is boxed. Identity values 
are at the right side. Ol, Oryzias latipes (medaka); Ga, Gasterosteus aculeatus 
(stickleback); Gg, Gallus gallus (chicken); Tg, Taeniopygia guttata (finch); Bt, Bos 
taurus (cattle); Md, Monodelphis domestica (opossum); Oa, Ornithorhynchus 
anatinus  (platypus); Mm, Mus musculus (mouse); Hs, Homo sapiens (human); Dr, 





Nanog  Ol  KAKVRAAFSESQMSTLVQRFSVQRYLTPAEMKNLADVTGLTYKQVKTWFQNRRMKLRRHQ 100%
Nanog  Ga  KGKMRAAFSESQMSALVQRFSIQRYLTPAEMKNLAEMTGLTYKQVKTWFQNRRMKLRRHQ 90%
Nanog  Dr  PRKTRAAFSEEQMNALVNRFNVQRYLTPAEMKTLAGATGLTYKQVKTWFQNRRMKLKRHQ 80%
Nanog  Md  KPKMRTVFSQAQLNVLNSRFVEQKYLSPQQIRNVAENLNLTYKQVKTWFQNQRMKSKRWQ 53%
Nanog  Oa  KSKIRTAFTQTQLNTLNRRFQTQKYLSPQQIRDLAMSLNLTYKQVKTWFQNQRMKSKRDR 53%
Nanog  Gg  KAKSRTAFSQEQLQTLHQRFQSQKYLSPHQIRELAAALGLTYKQVKTWFQNQRMKFKRCQ 62%
Nanog  Tg  TGKSRTAFSQEQLKALHQRFQSQKYLSPQQIRELAAALELTYKQVKTWFQNQRMKFKRCQ 55%
Nanog  Bt  KQKIRTVFSQTQLCVLNDRFQRQKYLSLQQMQELSNILNLSYKQVKTWFQNQRMKCKKWQ 48%
Nanog  Hs  KQKTRTVFSSTQLCVLNDRFQRQKYLSLQQMQELSNILNLSYKQVKTWFQNQRMKSKRWQ 50%
Nanog  Mm  KQKMRTVFSQAQLCALKDRFQKQKYLSLQQMQELSSILNLSYKQVKTWFQNQRMKCKRWQ 50%
Nkx2.3 Dr  RRKPRVLFSQAQVFELERRFKQQRYLSAPEREHLASTLKLTSTQVKIWFQNRRYKCKRQR 47%
Nkx2.5 Ol  RRKPRVLFSQAQVYELERRFKQQRYLSAPERDHLASVLKLTPTQVKIWFQNRRYKCKRQR 48%
Nkx2.5 Dr  RRKPRVLFSQAQVYELERRFKQQKYLSAPERDHLANVLKLTSTQVKIWFQNRRYKCKRQR 47%
Nkx6.1 Dr  RKHTRPTFSGQQIFALEKTFEQTKYLAGPERARLAYSLGMTESQVKVWFQNRRTKWRKRH 40%
Ved    Dr  GRRPRTAFSSEQISSLERVFKRNAYLGAQDKAELCRTLKLTDKQIRNWFQNRRMKLKRTV 42%
Vent   Dr  NRRVRTKFTCDQISGLEKSFSKHRYLGATQRRKIAEKLHLSETQVKTWFQNRRMKLKREV 45%
Vox    Dr  TRRIRTKFTPEQIDKLEKIFNKHKYLDAGERVKTALKLGLSETQIRTWFQNRRMKLKREV 38%
Vent   Hs  APRVRTAFTMEQVRTLEGVFQHHQYLSPLERKRLAREMQLSEVQIKTWFQNRRMKHKRQM 47%
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Fig. 3-4 Genomic organizations of nanog, vent and nkx2.5. Nanog has 4 exons 
whereas vent and nkx2.5 have 3 and 2 exons, respectively. (A) nanog. Asterisks 
demarcate positions encoding YKQ and VKTWFQN comprising the unique motif 
YKQVKTWFQN. Conserved exon-intron junctions spanning sequence coding for the 
unique motif are shown in the bottom. Exons are shown in capital; introns in lower 
case letters. The splicing donor and acceptor are in bold. (B) vent. (C) nkx2.5. Open 
box, nontranslated exon; filled box, translated exon; lines between boxes, introns; 




Fig. 3-5 Protein domain structure of Nanog. (A) Comparison of domains of Nanog 
proteins. Mouse Nanog contains a WR sub-domain with 10 WXXX repearts in its 
C-terminal, while Ong only contain one WXXX in the equivalent region. (B) 
Alignment of Ong with mouse Nanog. Sequence comparison shows much similarity 
between the two homologues. The overall identity is 16.4%. Boxed region is 
homeodomain. Underlined region is mouse WR domain. ND, N-terminal domain; HD, 
Homeodomain; CD, C-terminal domain, CD was subdivided into CD1, WR and CD2 
domains; WR, C-terminal sub-domain with WXXX repeats.  
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Fig. 3-6 Phylogenetic tree of Nanog homologues and other homeoproteins. Nanog 
family is indicated by grey color. All Nanog proteins are clustered together but 
separated from related homeoproteins such as Nkx2 and Vent family (including vent, 
ved and vox). Protein accesession numbers are provided following organism’s names. 





3.1.3 Phylogenetic analysis 
To explore the phylogenetic relationship of Nanog homologues, alignment analysis 
was performed and phylogenetic tree was constructed using Vector NTI software. The 
results revealed that the medaka Nanog belongs to the clade of Nanog family and is 
clustered together with fish Nanog homologues, but separated from other related 
homeobox factors such as Nkx2 and Vent family (including vent, ved and vox)(Fig. 
3-6).  
3.1.4 Synteny analysis of Ong 
Ong gene locates on chromosome 20 flanked by Ipo4 and Tm9sf1. In human, IPO4 
and TM9SF1 are on chromosome 14. However, no gene can be found or predicted 
between the two genes. Human NANOG locates on chromosome 12 with Clec4c and 
Sca2a14 as neighbors (Fig. 3-7). However, Clec4c and Sca2a14 cannot be found in 
medaka genome. Aicda and Foxj2 usually cluster with nanog in mammalian and 
chicken genome. Nevertheless, these two genes do not cluster with fish nanog 
homologues in fish genome, suggesting significant gene re-arrangements happened 
since fish lineage separated from tetropod. An interesting phenomenon is that the 
synteny structure is even not conserved in teleost group. Medaka, Fugu, Tetraodon 
and stickleback share similar synteny structure, i.e. Ipo4-nanog-tm9sf1. Nevertheless, 



















Fig. 3-7 Chromosomal location and synteny analysis of Ong. Ong gene locates on 
chromosome 20 flanked by IPO4 and Tm9sf1. Human Nanog locates on chromosome 
12 with Clec4c and Sca2a14 as neighbors. Human IPO4 and TM9SF1 locate on 
chromosome 14, where no gene exists between them. Aicda and Foxj2 cluster with 
nanog in mammalian and chicken genome, but in fish, they are distributed on 
different chromosomes. In medaka, for example, nanog is on Chr20 while Aicda and 
Foxj2 are on Chr16. 
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3.1.5 Expression analysis 
3.1.5.1 Spatial and temporal expression analysis by RT-PCR 
In mouse, Nanog is predominantly expressed in ES cells, ICM, posterior epiblast 
before the end of gastrulation and migrating and proliferating primordial germ cells. 
To investigate Ong expression, RT-PCR was performed on adult tissues. Unlike 
mouse nanog, Ong transcripts were detected in adult testis and ovary (Fig. 3-8A) 
using a pair of primers (the forward primer spanning exon 3 and exon 4 and the 
reverse primer from 3’UTR region) which can amplify a nanog cDNA fragment but 
not genomic DNA. As anticipated, ong is expressed in medaka ES cells (MES1) (Fig. 
3-8A). Distinct from mouse nanog, ong is maternally supplied. Its embryonic 
expression could be easily detected from morula (stage 8) to late gastrulation (stage 
16) (Fig. 3-8B) with a gradually down-regulated manner. From late gastrulation 













Fig. 3-8 RT-PCR analysis of Ong. (A) Ong is expressed in adult gonads and medaka 
ES cells (MES1). (B) Ong is mainly expressed in early stages before neurula. In late 


















3.1.5.2 Expression analysis in ovary by ISH 
To further investigate Ong expression in more detail, we applied whole mount (WISH) 
and section in situ hybridization (SISH) techniques. By WISH, we detected strong 
signals in stage I oocytes (Fig. 3-9A, B). Considering the probe penetration problem 
in larger oocytes, adult fish ovary was cross-sectioned and SISH was performed. 
When examined the sections in detail, we found that signals were present in oocytes 
from stage I (diameter 20~60 um) to stage VI (diameter 250~400 um, vitellogenic 
stage) (Fig. 3-9C). The weak signals in stageVI may be attributed to the dilution by 
the growing yolk substance. Importantly, nanog transcripts also present in oogonia 
(Fig. 3-9D, E, F), suggesting that nanog may play essential roles for self-renewal of 
oogonial stem cells. 
3.1.5.3 Expression analysis in testis by ISH 
WISH on testis was performed to examine nanog expression. Ong transcripts were 
found to be in the periphery region, where putative spermatogonial stem cells 
localized (Fig. 3-10A). Section ISH (SISH) results confirmed that Ong mRNA 
expression restricted in a cluster of typical spermatogonial stem cells in each 
spermatogenetic cyst (Fig. 3-10B, C, D,). Unlike zebrafish and mouse, medaka 
spermatogonial cells locate at the periphery of each spermatogenetic lobulars in testis. 
As shown in Fig 3-10B, there are at least 10 spermatogenetic cysts with positive 
staining in left or right half testis. Detailed examination revealed that about 3-4 
strongly stained spermatogonia-like cells with several weak stained spermatogonia 
surrounding in each spermatogenetic cyst (Fig. 3-10C, D). 
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Fig. 3-9 Ong mRNA expression in oocytes and oogonia of adult ovary. (A, B) 
Whole mount ISH. The signals mainly present in stage I oocytes (arrows). (B) Higher 
magnification. Scale bars, 100 μm. (C) Section ISH. Ong transcripts can be detected 
from stage I to stage VI. (D, E, F) Ong transcripts in oogonia (arrow). (D) 40×. Scale 






Fig. 3-10 Ong RNA expression in adult testis. (A) Whole mount sample showing the 
signal in the peripheral cysts, putative spermatogonia (arrow). Dotted line indicates 
the middle efferent ducts. (B-D) Cryosections. The signal is seen in the spermatogonia 
(arrows; B), barely detectable in primary spermatocytes (sc1), absent in secondary 
spermatocytes (sc2), spermatid (st) and sperm (sm). At larger magnifications, the 







3.1.5.4 Expression in early embryonic stages 
WISH on early embryos was performed to examine the expression of Ong. Strong 
signal was detected at cleavage stage (Fig. 3-11A, B, C), further suggesting its 
maternal expression. About 18 spokewise stripes around the cell mass were seen, 
suggesting the maternal mRNA message was not stored in animal pole of the oocytes. 
In morula stage, the signal was restricted to inner embryo proper cells but not 
periphery cells (asterisks) (Fig. 3-11D). In blastula stage, expression starts to decrease 
but still in the central cells (Fig. 3-11E, F). Detail examination by cross section 
revealed that the signal was rich in deep cells but absent in evenlope layer (EVL) and 
yolk syncitial layer (YSL) (Fig. 3-11G, H).  
During gastrulation, Ong RNA is specifically restricted to migrating primordial 
germ cells (PGCs). At 30% epiboly, about 40 typical PGCs (spots like distribution) lie 
symmetrically beside embryonic shield (es). The shield region also has weak signal. 
At 50% and 75% epiboly, only PGCs give rise to positive signal. After gastrulation, 
the signal is not easily detected by chemical ISH. By fluorescent ISH, it was found 
that nanog transcripts were still abundantly expressed in dazl, a well investigated 






Fig. 3-11 Ong RNA expression during early embryogenesis till blastula by WISH. 
(A-F) Top view; (G-H) Lateral view, with the animal pole on top. (A) 2-cell stage. 
Besides in the cells, the signal is also detected on the yolk surface stripes (asterisks) 
from vegetal to animal pole. (B) 4-cell stage. The signal is more concetrated into cells 
and gradually declined in the stripes (asterisks). (C) 4-cell blastoderm dissociated 
from the yolk, shows that the signal is preferentially distributed in the cells, but absent 
in the yolk membrane (ym). (D) 128-cell stage exibits a dynamic distribution. The 
signal is rich in inner cells but absent in the marginal region in 2-3 cells thickness 
(asterisks). (E-F) 1000-cell midblastula stage after WISH and nuclear staining by 
DAPI (blue), shows the absence of signal in the outermost cells of the periblast 
(arrows). (G-H) Cryosection of embryos at early (G) and middle (H) blastula stage. 
The signal is rich in deep cells but absent in EVL and YSL. dc, deep cells; EVL, 




Fig. 3-12 Ong RNA expression in primordial germ cells. (A-C) Gastrulation stages 
by chemical WISH. The signal sequentially declines to a barely detectable level in the 
majority of cells but remains abundant in approximately 40 cells (asterisks) 
surrounding the embryonic shield (es). Broken lines demarcate the epiboly edge. (D-I) 
Stage 21 embryos after dual color FISH. (D) Ong antisense probe. (E) dazl antisense 
probe. (F-G) Merged image of dazl and nanog signals. (H-I) High magnification of 
the posterior region. The insert inside I is merge of nanog and dazl signals, 
highlighting colocalization of dazl and nanog RNAs into speckles. (A-C) Lateral view, 
with the animal pole being to the top. (D-I) Dorsal view, with the anterior to the left. 
Scale bars, 0.2 mm. 
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3.1.5.5 Protein expression analysis by western blot 
To examine Ong protein expression, we raised an antibody against Nanog full-length 
peptide. The antibody recognized a band at the size of ~48 kDa (calculated MW 
46kDa) in ES cells. A lower band of ~46kDa was detected in testis and ovary. Of 
interest, both bands (46kDa and 48kDa) could be detected in morula sample (Fig. 
3-13A). There are at least two possibitities for the bands in different size. One is that 
nanog protein was phosphorylated in ES cells. The other may be that there are nanog 
isoforms, that is to say, only the smaller isoform is expressed in gonads, the larger in 
ES cells and both isoforms in morula stage embryos. To clarify this issue, further 
investigation is required, eg. dephosphorylation of protein or a northern blot. 
3.1.5.6 Ong protein localization in ES cells and morula blastomeres 
To examine Ong protein localization in vitro and in vivo, immunostaining was 
performed and the results demonstrated its nuclear localization in cultured ES cells 
(Fig. 3-14). To further confirm the nuclear localization of Ong protein, a His-tagged 
Nanog fusion protein vector pCVpfCVong was introduced into ES cells and α-His 
antibody was applied to immuostaining, the results also indicated that Ong was 
localized in nucleus of ES cells. Using Nanog antibody to stain the ES cells, the signal 
mainly presents in the nucleus (Fig. 3-14E-G). When ES cells were co-expressed with 
Ong:GFP and RFP protein, the dominant nuclear localization of Ong:GFP strongly 
indicated that Ong could function as a transcription factor in ES cells (Fig. 3-14C). 
When Ong:GFP mRNA was injected into 1-cell embryo, the GFP signal localized in 
the nucleus of blastomeres (Fig. 3-14H-J). Taken together, Ong is is a nuclear protein 
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and expressed in pluripotent cells in vivo (blastomeres) and in vitro (ES cells). 
 
Fig. 3-13 Ong protein presents in gonads and ES cells. (A) One predominant band 
of ~46kDa in size was detected in testis and ovary samples. A larger band of ~48kDa 
appeared in ES cell sample. Both bands were detected in morula sample. (B) Negative 




Fig. 3-14 Nanog protein expression and nuclear localization in medaka ES cells 
and embryos. (A) Constructs used for cell transfection and synthesis of RNA for 
embryo injection. pCVpfCVong is a bicistronic vector, expressing two fusion proteins 
driven by the cytomegalovirus enhancer/promoter (CV). One is Puromycin fused with 
GFP (pf), the other is Ong with a His-tag. pDs-Red expresses RFP. (B-C) showing 
nuclear localization of Ong-derived protein in ES cells. MES1 was transfected with 
pCVpfCvong and stained with α-His-tag antibody (red) and the nuclear dye DAPI 
(blue). (C) Showing nuclear localization of the Ong:GFP fusion protein in ES cell. 
MES1 were contransfected with pCSong:gfp and pCVpr and observed at day 3 
posttransfection. (D) Growing ES cells. (E-G) Fixed ES cells after being stained with 
Nanog antibody (red) and DAPI.  (H-J) Showing nuclear localization of Ong:GFP 
fusion protein from zygotically injected Ong:gfp mRNA. Inserts showing a 
blastomere dissociated from the embryo, highlighting nuclear Ong:GFP and 
cytoplasmic RFP. During photophraphy, the cell actively changed its shape and 
position by forming pseudopodia (asterisk). Scale bars, 20 μM. bm, blastoderm; at, 
attaching filament; od, oil droplet. 
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3.1.5.7 Ong protein localization in ovary 
Nanog, as a transcription factor, should be preferentially localized in the nuclear of 
cells, which has been demonstrated in the above and by investigations in other 
organisms. However, to our surprise, Ong protein in ovary was mainly enriched in 
cytoplasmic Balbiani body-like (BB) structure in previtellogenetic oocytes (Fig. 3-15). 
Balbiani body (also called mitochondrial clound, MC ) is a large distinctive organelle 
aggregate found in ealy developing oocytes and contains germ cell fate determinant 
called germ plasm/germinal plasm/polar plasm/pole plasm/oosome/nuage in most 
animal species including insects, Xenopus, fish and mouse (Pepling et al., 2007). 
Meanwhile, moderate signals were also detected in particles and distributed in nuclear 
region of the oocyte (Fig. 3-15F, G). Although we still don’t know why Ong protein is 
localized to Balbiani body, one point is that Ong has distinct special roles in 
gametogenesis and germ cell development.  
3.1.5.8 Ong protein expression in germ cells of fry fish 
Ong is expressed in the inner cell mass of pregastrulation embryos and thereafter 
restricted to germ cells as revealed by the RNA examination. As described earlier in 
this chapter, in late stages of embryos, the expression of ong gene is not easily 
detected by chemical ISH or RT-PCR. To further demonstrate the expression of Ong 
in late stages (after hatching) of fish development, cross section and immunostaining 
were conducted. In male (about 15 dpf), Ong protein mainly presents in the nucleus of 
Vasa (a well studied germ cell marker) positive cells (Fig. 3-16B-G). In female 






Fig. 3-15 Ong protein localization in oocytes. (A-H) Ong protein is localized to 
balbiani body (BB) like structure in stage I oocytes. Arrows indicated the signal. (A-C) 
Three oocytes with strong staining (red arrows). (B) DAPI staining shows the oocyte 
boundary. (C) Merged image. (D-G) A second sample. (D) Bright field view. (E) 
DAPI staining. (F, G) Ong protein localizes to both nucleus and BB of stage I oocytes. 
Arrow head shows the signal in the nucleus. (G) Merged image of D, E and F. (H) 
whole view of cross section from 1-month-old female fish. 
 92
 
Fig. 3-16 Ong protein is localized to Vasa positive germ cells in male fry. (A) 
cross-section. Boxed region contains the germ cell. (B) The germ cell was stained 
with αVasa antibody. (C) αNanog staining. (D) DAPI staining. Arrow indicates a 
typical nucleus of pluripotent cells such as PGCs or gonia. (E-G) merged images. 
 
Fig. 3-17 Ong protein is colocalized with Vasa in female germ cells. (A) αVasa 
staining (arrow) (B) αNanog staining (arrow). (C) DAPI staining. (D-F) merged 
images. 
Vasa Nanog DAPI 
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3.1.6 Functional analysis 
3.1.6.1 Function analysis by overexpression in ES cells. 
The primary function of nanog was demonstrated in mouse ES cells where Nanog is 
necessary and sufficient for ES cell proliferation in an undifferentiated status 
(Chamber et al., 2003; Mitusi et al., 2003). We made use of medaka ES cell line 
(MES1) to test whether Ong played a similar role as mouse Nanog in ES cell 
self-renewal. To clarify this, we utilized the bicistronic plasmid pCVpfCVong, 
expressing a fusion pf gene (puromycin resistance and gfp) and the Ong from the 
strong CV enhancer/promoter (Fig. 3-18), transfected into MES1 cells. Transfectants 
were subjected to 1-day pulse-selection with puromycin (final concentration, 1 mg/ml) 
to enrich the transgenic cells, then subcultured and grown in the absence of growth 
factor bFGF. Under these conditions, control MES1 cells transfected with pCVpf only 
expressing the pf fusion protein gave rise to only differentiated derivatives, whereas 
pCVpfCVong transfectants during 15 days of culture were able to produce seemingly 
undifferentiated cells which were GFP-positive. To further demonstrate Ong 
expression is sufficient for clonal expansion under culture conditions without the 
growth factor bFGF, we let the transfectants grow under drug selection using 
purimycin (final concentration, 1 mg/ml). After three weeks selection, only cells with 
pCVpfCVong can form colonies. Cells similarly transfected with control plasmid 
pCVpf exhibited overt differentiation and usually died within 10 days of culture, with 
few cells, where GFP expression is undetectable, surviving beyond and without 
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forming compact colonies of seemingly undifferentiation cells (Fig. 3-19). Taken 
together, these results suggest that Ong resembles the mouse Nanog prototype in that 
its overexpression is sufficient to support the undifferentiated growth of ES cells 
under otherwise differentiation culture conditions.  
3.1.6.2 ES cell identity is associated with Ong expression 
MES1 is a medaka ES cell line derived from mid-blastula stage embryos and undergo 
self-renewing proliferation in the complete medium ESM4 containing growth factors 
bFGF and medaka embryo extract (MEE) (Hong et al., 1996; Hong et al., 1998). 
MES1 retains pluripotency for chimera formation (Hong et al., 1998), and is capable 
of spontaneous differentiation (Hong et al., 1996), directed differentiation by ectopic 
mitf expression (Bejar et al., 2003), and induced differentiation in the absence of 
added growth factors. After six days of culture in the absence of growth factors, 
MES1 exhibited a differentiated phenotype with flattened morphology. Meanwhile, 
RT-PCR and Western blot analyses showed that the expression of Ong RNA and its 
protein product was dramatically decreased or lost when ES cells began to 
differentiate (Fig. 3-20). The result suggests that Ong RNA and protein expression 




Fig. 3-18 Ong over-expression is sufficient to prevent ES cell from differentiation. 
MES1 cells were transfected with either pCVpf or pCVpfCVong and maintained in 
ESM4 for undifferentiated growth for two days. Following growth in ESM2 
containing puromycin (mg/ml) for pulse selection for transgenic cells, the cells were 
subcultured onto 10-cm dishes in the absence of added growth factors to allow for 
spontaneous differentiation. At day 6, pCVpfCVong positive cells still had 
undifferentiated morphology (small and round), whereas pCVpf positive cells 




Fig. 3-19 Ong over-expression is sufficient for clonal expansion of ES cells in the 
absence of growth factor bFGF. MES1 cells were transfected with either pCVpf or 
pCVpfCVong and maintained in ESM4 for undifferentiated growth for two days. The 
cells were then subcultured onto 10-cm dishes in bFGF-depleted ESM4 containing 
puromycin (1 mg/ml). Only cells with pCVpfCVong (green color) can form colony 
after 20 days of culture. Cells with control plasmid pCVpf did not form compact 
colonies (data not shown). Although some cells without plasmid integration can 








Fig. 3-20 ES cell differentiation is associated with loss of Ong expression. (A) 
Phenotypic differentiation of medaka ES cells. MES1 cells were cultured for indicated 
days in the absence of growth factors. At the beginning of experiment, 
undifferentiated MES1 cells are small in size and round in shape. They differentiated 
from day 6 onwards to larger and flattened cells containing vacuoles (arrows). (B) 
RT-PCR analysis of Ong RNA expression. (C) Western blot analysis of Ong protein 
expression. The Ong RNA and protein product were abundant during the first three 
days and disappeared beyond three days of culture in growth factor-depleted medium. 







3.1.6.3 Dominant Negative Mutant analysis 
Both Ong mRNA and protein are stored in oocytes for early development. To explore 
the function of nanog in early development, dominant negative mutant (DNM) 
analysis was done. A DNM Nanog form ‘OngDN2’ was generated by deletion of the 
last 57 C-terminal amino acids which was equivalent to mouse CD2 subdomain. 
Another truncated DNM nanog ‘OngDN1’ was generated by deleting whole 
C-terminal domain (Fig. 3-21). Injection of OngDN1 up to 400pg did not cause any 
abnormal phenotype and therefore OngDN1 was used as control mRNA. Injection of 
200pg OngDN2 caused embryo development arrested at morula-blastula stage (Fig. 
3-21). Injection of 100pg OngDN2 did not cause any dominant negative effect. These 
results indicated Nanog C-terminus was essential for protein-protein interaction and 
Ong was required for the cleavage stages during early embryogenesis. To further 
confirm the dominant negative effect, a third DNM ‘OngDN3’ was generated by 
replacing the last 43 amino acids with EGFP. Embryos injected with OngDN3 mRNA 
could go through blastula stage but the cells were disorganized with enlarged size 
early at gastrula stage, indicating that Ong may play essential roles in cell 
proliferation and epiboly movement (Fig. 3-22). Both DNMs has dominant negative 
effects while OngDN2 was stronger than OngDN3. These results suggest embryos 
interfered by mutant nanog could neither form epiblast nor fulfill gastrulation. The 
disorganized big cells by OngDN3 injection could not participate in the formation of 
three germ layers, suggesting these cells were either unspecified or differentiated into 
extraembryonic tissues. In mouse embryo, loss of nanog results in ICM differentiation 
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into extraembryonic endoderm tissues with no discernible epiblast (Mitsui et al., 
2003). Therefore, the phenotype caused by DNM injection in medaka displayed some 
similarity to the phenotype caused by nanog knockout in mice. Future identification 
of extraembryonic (endoderm) markers in medaka would provide useful information. 
In summary, medaka nanog is essential for pregastrula embryo development, possibly 













                                                                       
 
Fig. 3-21 DNM analysis of Ong in early development by injection of OngDN2. 
Embryos were injected with OngDN2 (200pg) plus GFP mRNA (20pg) or OngDN1 
(200pg) plus GFP mRNA (20pg) at 1-cell stage as control. (A, D, G) control embryos. 
(B, C, E, F) coinjection of OngDN2 and GFP mRNA. (B, C) the embryo development 
was retarded. (E, F) the embryos arrested at late morula while control was already at 





Fig. 3-22 DNM analysis of Ong in early development by injection of OngDN3. 
Embryos were coinjected with OngDN1+GFP mRNA (con) or OngDN3 (200 pg) at 1 
cell stage. (A, C) OngDN1+GFP mRNA injection. Injected embryos developed 
normally. (B, B’, D, D’) injection of OngDN3. The GFP signals are restricted to 
nucleus. (D, D’) embryonic cells were disorganized without normal epiboly while 






3.1.6.3 Functional analysis by Morpholino oligonucleotide (MO) knockdown  
Morpholino oligos are synthetic molecules which are the product of a redesign of 
natural nucleic acid structure and thereby are RNase resistant (Summerton and Weller, 
1997). Usually 25 bases in length, they bind to complementary sequences of RNA by 
standard nucleic acid base-pairing and function by blocking mRNA translation or 
interfering with pre-mRNA processing to have knockdown effects. Structurally, the 
difference between Morpholinos and DNA is that while Morpholinos have standard 
nucleic acid bases, those bases are bound to morpholine rings instead of deoxyribose 
rings and linked through phosphorodiamidate groups instead of phosphates.  
To understand the roles of nanog during early development we applied antisense 
morpholino oligonucleotides (MO). Two anti-sense MOs were designed, namely, 
OngMO1 (TGACCTGAGTTTTCCACTCCGCCAT, binding sequence from ATG), 
and OngMO2 (GGGAAACCGTCTTCTCAAAACCGTA, binding sequence in 
5’UTR between -34 nt and -19 nt from ATG). Both MOs caused similar phenotypes, 
but OngMO2 is more effective than OngMO1 at higher concentration. The specificity 
of inhibition of translation of nanog mRNA by OngMO1 was confirmed by the 
effective inhibition of GFP fluorescence when co-injecting OngMO1 with 
OngMO1-GFP chimeric mRNA which was transcribed from a construct generated by 
fusing OngMO1 binding site sequence in frame to GFP CDS, as shown in Fig. 3-23. 
For translation inhibition of nanog mRNA, various doses (1-3 pg) of MO was 
injected into medaka embryos of 1 cell stage and their development was monitored. 
B 
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The inhibition of nanog mRNA translation resulted in mild to severe phenotype 
depending on dose of injection. Injection of 1 pg MO1 did not cause any obvious 
phenotype (data not shown). Injection of 1.5 pg MO1 resulted in yolk vein missing 
concomitant with loss of blood circulation and smaller brain size at 72 hour (Class I 
phenotype) (Fig. 3-24B). Injection of 2 ng MO1 resulted in similar phenotype to class 
I but with prominent hook-like tail (Fig. 3-24F-G). Injection of 2.5 ng resulted in 
gastrulation defect with enlarged cell size. Injection of 3 ng MO2 caused severe 
proliferation and epiboly defects. Morphants had slow proliferation rate from late 
morula stage and resulted in less blastomeres with enlarged size. Although the 
embryos could enter into blastula and gastrula, they arrested before 50% epiboly 
because unsufficient cell number for epiboly movement (Fig. 3-25). Interestingly, 
becase the epiboly movement still go on regardless of less cell number, convergence 
results in most of enlarged cells move to the dorsal (shield) region and leave the 
ventral side with just a few sparse cells. For each injection, at least 40 embryos were 
injected and the same phenotype appeared in more than 70% total embryos were 
defined as phenotype attributd by that MO dose. 
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Injected embryos were screened at 5 hpf (morula stage) to remove abnormal embryos. 
All embryos were monitored at 10, 24 and 72 hpf. Class III and class IV have severe 










Table 3-1 Dose-dependent phenotypes by OngMO knockdown 
                                             Phenotype classes         
Morpholino  conc.   embryos  WT    Class I    class II   class III   class IV
            ng/nl   injected  (%)     n (%)     n (%)     n (%)    n (%) 
MOC        3.0     40     40(100%)  
OngMO1     1.5     64              6(9%)   50(78%)   8(13%) 
OngMO1     2.0     52                      6(12%)   46(88%) 
OngMO1     2.5     43                      3(7%)    32(74%)   8(19%)




Fig. 3-23 Examination of OngMO1 specificity. Embryos were injected at the 1-cell 
stage with RNAs at indicated doses and monitored for development until 48 hpf. (A) 
Chimeric OngMO1gfp RNA. The 25-nt Ong 5’ sequence (red) as the target for 
antisense morpholino oligo OngMO1 and a 5-nt linker (black) are fused in frame to 
gfp coding sequence. (B) Injection of OngMO1gfp RNA. Embryos developed 
normally and expressed GFP.  (C) Co-injection of OngMO1gfp RNA and OngMO1 
(labbled with lissamine, red color; 1 ng/embryo). Embryonic development appeared 
normal. Only the red MO color was visible. egfp expression (green color) was 





To confirm the MO1 effect, a third splicing MO (MO3) was applied. Injection of 4 ng 
MO3 resulted in no obvious phenotype. Injection of 6ng could duplicate phenotypes 
produced by MO1, such as smaller head (brain and eye), loss of yolk vein, but without 
showing severe epiboly defects. To summarize the phenotype by MO injection, loss 
of yolk vein, formation of hook-like tail (tail defects) and epiboly defect are typical 
phenotypes. These phenotypes are not consistent with its expression pattern, forcing 
us to consider the embryo patterning problem. Zebrafish is a well established model 

















Fig. 3-24 Classification of phenotypes caused by OngMO1 knockdown. (A, D, H) 
control embryos at 72h, 72h and 24 h, respectively. (B, C) Typical phenotype at dose 
1.5 ng. Morphant displayed smaller brain (white arrow) and loss of yolk vein (black 
arrows), but the tail is almost normal (arrow head). (E, F, G) Morphants displayed 
hook-like tail (arrows) at 72 h. Yolk vein was still missing. (E) Blood formed but 
clotted (white arrow). (G) Red fluorescence of MO clearly indicated the tail defect 
(arrow). (H, I, J) Morphants displayed gastrulation defects. Epilboly was delayed (I) 






Fig. 3-25 Phenotype class IV caused by OngMO2. (A, C) control embryos. (B) 
From late morula, morphants displayed slow proliferation rate and had enlarged 
blastomeres with less cell number. (D-F) Morphants arrested at 30% epiboly with 
more cells in dorsal side while less cells in ventral side. (E) Ventral cells were 
separate and sparse, lack of adhension (black arrows). White arrow indicates YSL. (F) 
Most of cells move to the dorsal side with few cells left in the ventral side. Dotted line 
indicates the boundary of dorsal and venral half. 
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3.1.6.4 Rescue of knockdown phenotypes by mouse nanog 
To further testify the MO knockdown phenotypes are specific and Ong is a real 
homolog of mammalian nanog, we used mouse nanog mRNA to rescue the morphants. 
Injection of 3 ng OngMO2 (MO1 targets to ATG region and is not convient for resue. 
MO2 targets to nanog 5’UTR) caused 100% Class IV phenotype displaying severe 
epiboly defects without any visible axis formation. Coinjection of 200 pg mouse 



















Fig. 3-26 Rescue of OngMO knockdown phenotype by mouse nanog mRNA. (A) 
Control embryo with phenol red injection. (B) MO injection only. Morphant displayed 
epiboly arrest without visible axis. (C-D) MO and mouse nanog mRNA coinjection. 






3.1.7 Ong is required for cell fate decision 
Ong knockdown led to lower proliferation rate, enlarged blastomeres and delayed 
epiboly. Whether Ong determines cell fate is not clear. To this end, we performed cell 
lineage analysis during blastula stages. We found eomesodermin, a maternal T-box 
factor for endoderm induction, was upregulated by OngMO2 knockdown. Whereas, 
vox (ventral homeobox gene), sox32 (earliest endoderm lineage marker) were 
downregulated by OngMO2 knockdown (Fig. 3-27). Eomesodermin (eomes) is 
maternally expressed in marginal blastomeres during zebrafish cleavage stages and 
required for endoderm induction (Bjornson et al., 2005). Marginal blastomeres 
contribute to future extra-embryonic tissues [the enveloping layer (EVL) and the yolk 
syncytial layer (YSL)] (Kimmel and Law, 1985). Therefore, eomes is an 
extraembryonic cell lineage marker in teleost. In mouse, eomes is expressed in 
trophoblast cell lineage before gastrulation (Russ et al., 2000). Eomes is conserved 
across vertebrates and the common target of Nanog, Oct4 and Sox2 in human and 
mouse ES cells (chip data) (Boyer et al., 2005; Loh et al., 2006). Considering Ong 
expression is restricted to central blastomeres, it is reasonable to speculate that nanog 
and eomes are repulsive and repress each other in early stage. 
 Vent homeobox genes (vent, ved and vox) are required for ventral cell fate 
specification in zebrafish (Gilardelli et al., 2004; Imai et al., 2001; Melby et al., 2000; 
Shimizu et al., 2002). Ong knockdown results in decrease of vox expression in the 
initial step (6.5 hpf, early blastula stage) but not later blastula stage (7.5-8.5 hpf). 
 Sox32 (casanova) is a High Mobility Group (HMG) box protein and 
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cooperatively function with Pou2/Oct4 to specify endoderm in zebrafish. It is one of 
the earliest enoderm marker genes (Alexander et al., 1999; Aoki et al., 2002; 
Dickmeis et al., 2001; Kikuchi et al., 2001; Lunde et al., 2004; Reim et al., 2004). 
Ong knockdown results in decrease of sox32 expression in the initial step (7.5-8.5 hpf, 
blastula stage). 
 Importantly, Ong positively activate zygotic pou2/oct4 expression (Fig. 3-28). In 
zebrafish, Pou2 is required for DV (dorsal-ventral) patterning, enoderm specification 
and brain development (Burgess et al., 2002; Lunde et al., 2004; Reim et al., 2004; 
Reim et al., 2006). Loss of pou2 results in multiple defects in early development. The 
phenotypes caused by OngMO are partly mediated by reduced expression of pou2.  
Interestingly, Ong knockdown results in enhanced expression of ntl, suggesting 
Ong represses ntl (Fig. 3-28). This is consistent with the results in Xenopus, where 
Oct25 and Oct60 can repress xbra transcription by inhibiting FGF and Nodal signal 












Fig. 3-27 Ong knockdown affects blastula cell fate. In early blstula (6.5 hpf), vox 
expression was reduced. In later blastula stage (7.5-8.5 hpf), vox expression was 
restored to normal level. Eomes was upregulated during blastula stage by OngMO 
knockdown. sox32 is initiated from ~7.5 hpf and its expression was reduced by 
OngMO knockdown. OngMO2 was injected at a dose of 3 ng. 
 
 
Fig. 3-28 Ong knockdown led to down-regulation of pou2 and up-regulation of 
ntl. At 30% epiboly, pou2 expression in morphants was reduced. Wheras, ntl 
(homolog of zebrafish no tail) expression was enhanced. Morphants has delayed 
epiboly. When morphants reached 30% epiboly, the normal embryos were already at 
90% epiboly stage. Here, control embryos at 30% epiboly were used for comparision. 
 114
3.2 Discussion 
3.2.1 Ong is specifically expressed in pluripotent cells 
Nanog, Oct4 and Sox2 are generally considered as the core transcription factors 
regulating ES cells pluripotency and differentiation. The appropriate level of the three 
factors is critical in maintaining ES cells pluripotency. However, both oct4 and sox2 
are expressed in developing neural tissue (Avilion et al., 2003; Reim and Brand, 2002). 
Nanog was firstly identified as specific marker in pluropotent cells including ES cells, 
EG cells, EC cells and PGCs by northern blot. Later its expression domain was 
extended to multiple adult tissues by ISH, RT-PCR or immunostaining methods (see 
introducton). Without exception, it is still only appear in pluripotent/mutipotent cells 
such as MSC or pre-committed tissue like posterior epiblast. No expression can be 
detected in any differentiated cell types. All these suggest nanog can be regarded as 
pluripotent/multipotent marker, promoting proliferation and/or playing 
anti-differentiation roles in stem cells or progenitor cells. 
    Ong is indeed expressed in MES1, an ES cell line isolated from blastula stage 
embryo. Upon MES1 cells begin to differentiate, Ong mRNA and protein level 
decrease accordingly. This suggests Ong expression is restricted to undifferentiated 
stem cells and is a pluripotency associated factor. 
Interestingly, nanog expression in adult mouse testis has never been reported. 
However, it was detected in human adult testis (Clark et al., 2004), albeit that the 
signal was very faint. The weak signal indicates that nanog may be expressed in the 
undifferentiated spermatogonial stem cells. To prove this hypothesis, we focus on 
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nanog expression in the medaka testis. Indeed, medaka nanog can be readily detected 
in testis by RT-PCR. Using a special ISH staining program, we did detect specific 
nanog expression in spermatogonial (stem) cells. The in vitro counterpart of 
spermatogonia is SG3 cell line, the first cell line capable of producing motile sperm in 
vitro (Hong et al., 2004a). SG3 cells do express nanog abundantly and have similar 
pluropotency to MES1 (data not shown). This is consistent with recent results from 
mouse model (Guan et al., 2006). 
Both Nanog and Oct4 are expressed in primodial germ cells and are required for 
mouse germ cell development (survival) (Chambers et al., 2007; Kehler et al., 2004). 
In zebrafish, however, germ cell expression of Pou2, homolog of mammalian Oct4 
(Niwa et al., 2008) was never reported. Zebrafish Pou2 seems not to be required for 
germ cell development (Reim and Brand, 2006). Although medaka Nanog and Pou2 
are expressed in primordial germ cells, whether they play roles in germ cell 
development is still not clear. 
Noteworthly, Ong is expressed in oogonia of adult ovary, a kind of germ stem 
cells. This is different from mammals, in which no oogonia exist in adult ovary. 
However, human NANOG was reported to be expressed in fetal ovary at 20-29 
weeks of gestation (Clark et al., 2004), suggesting nanog may be expressed in human 
oogonia. If oogonial stem cell line has been generated, we can compare in more 
detail. 
3.2.2 Ong is maternally supplied 
Mouse Nanog is required to maintain early embryonic ICM cells to be in pluripotent 
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state prior to gastrulation. It is zygotically expressed from 16-cell stage by WISH 
method (Chambers et al., 2003). In unfertilized oocytes, no expression can be detected. 
However, both medaka and zebrafish nanog are maternally expressed in oocytes and 
1-cell stage embryo. This is different from amniotic animals but understandable. 
Lower vertebrates such as fish and frog undergo reductive rather than proliferative 
cell division during early cleavage (Frederick and Andrews, 1994; Kane et al., 1992). 
The cleavage speed is fast and no zygotic gene expression until middle blastula 
transition (MBT), which starts from 512-cell stage and is only 3 hours earlier than 
early gastrulation. It is impossible to maintain pluripotency of cleavage embryo cells 
by zygotic expression products. Therefore, fish adopt a different strategy: using 
maternal mRNA and protein storage rather than zygotic expression products to keep 
the cleavage embryo cells to be in a pluripotent state before MBT and gastrulation. 
That partly explains why medaka ES cells were isolated form middle blastula stage 
where zygotic nanog expression can start but not earlier or later stages. 
Upon gastrulation initiation, nanog transcripts quickly disappear and only present 
in primordial germ cells from then on. Gastrulation is the process of specification of 
three germ layers (ectoderm, mesoderm and endoderm). Down regulation of nanog in 
somatic cells is required during gastrulation. This regulation is possibly mediated by 
GCNF on the transcriptional level (Gu et al., 2005b).  
3.2.3 Expression in spermatogonia 
We notice that there are about 2-3 strongly stained spermatogonial cells with several 
surrounded weak stained spermatogonial cells in each spermatogenetic cyst. The 2-3 
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strongly stained spermatogonia are likely to be spermatogonial stem cells while the 
weak stained spermatogonia are committed spermatogonia or differentiating 
spermatogonia or primary spermatocyte. All the spermatogonia and their position 
composed the so-called ‘niche’ in each spermatogenetic lobular. It will provide a very 
good model for studying germ stem cells self-renewal in vertebrates. 
3.2.4 Expression in early cleavage stage 
The nanog expression pattern in morula stage is a novelty. The maternal mRNA 
molecules specially localize to the central blastomeres but not in marginal cells during 
early cleavage from 64/128-cell stage. Currently, only medaka simplet (FAM53B) has 
this kind of expression pattern. simplet was identified as a vertebrate-specific gene 
with no characterized biochemical domains, required for cell proliferation and 
probably associated with the maintenance of pluripotency (Thermes et al., 2006). It is 
believed that the central blastomeres generate the future embryo proper while the 
marginal blastomeres constitute the future extra-embryonic tissues [the enveloping 
layer (EVL) and the yolk syncytial layer (YSL)] (Kimmel and Law, 1985). Specific 
expression in the central blastomeres is regarded as to be associated with a cellular 
undifferentiated state and/or with an active cell proliferation. This kind of role is what 
Nanog does in mammalian embryos. This suggests that although the cleavage patterns 
between fish and mammals are different, same effect is still achieved by differential 
gene expression such as nanog and simplet. 
Notably, the differential expression pattern during cleavage was also found in 
zebrafish (Bjornson et al., 2005). Eomesodermin (eomes), a T-box transcription factor 
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required for endoderm induction, is maternally expressed and localized to marginal 
blastomeres during cleavage.  
3.2.5 Expression in primordial germ cells (PGCs) 
In vertebrates, germ cell lineage is separated from soma during gastrulation. Germ 
cell fate in mice is induced in proximal pluripotent epiblast cells by the 
extra-embryonic ectoderm, and is not acquired through the inheritance of any 
preformed germ plasm, which is required for germ cell specification in lower 
vertebrates such as fish (McLaren, 2003; Raz, 2003). In mice, immediately after/when 
germ cell specification, Nanog and Oct4 expression are already there and required for 
germ cell maturation or survival (Chambers et al., 2003; Scholer et al., 1990; 
Yamaguchi et al., 2005; Yeom et al., 1996). However, non-expression of pou2 has 
been detected in zebrafish primordial germ cells and pou2 is not required for germ 
cell development (Burgess et al., 2002; Reim and Brand, 2006). Therefore, Ong, a 
transcription factor, becomes one of the first markers when fish PGCs are specified 
during early gastrulation. This kind of expression is reminiscent of mouse nanog, 
suggesting conserved roles of nanog in germ cell development.  
3.2.6 Western blot analysis 
We developed an antibody against the recombinant medaka Nanog protein. The 
antibody detected one band in ES cells and another smaller band in gonads within 
anticipation. However, two bands are simultaneously recognized in morula sample. 
The appearance of two bands suggests the existence of isofroms or protein 
modifications. Future work is needed to elucidate this issue. 
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3.2.7 Function analysis by DNM analysis 
Nanog morphants display a series of phenotypes: arrest at late morula, delayed 
epiboly, enlarged blastomeres, smaller embryo body, tail defect and loss of yolk vein. 
The first three characters are very similar to smp, homolog of human FAM53B gene, 
morphants (Thermes et al., 2006). The medaka smp was proposed to be needed for 
cell proliferation and associated with the maintenance of cellular pluripotency. This is 
greatly in agreement with nanog as pluripotency regulator. 
Over-expression of nanog is sufficient for clonal expansion of mouse ES cells 
independent of LIF or feeder requirement (Chambers et al., 2003). Although mouse 
nanog-/- ES cells can propagate, they proliferate poorly and are prone to differentiation 
(Chambers et al., 2007). Nanog-/- mouse embryo failed to generate epiblast, only 
produced parietal endoderm-like cells (Mitsui et al., 2003). However, no nanog 
mutant or knockout fish is available. Knock-down phenotype is not as strong as to 
knockout because of the maternal protein there. That is why the mild morphants can 
still enter gastrulation, although incomplete, and develops to rod-like body with very 
smaller size and anterior-posterior axis. The tail defects are probably caused by 
patterning defect of tail organizer and the mis-expression of brachyury. Loss of yolk 
vein is possibly caused by reduced expression of vent family (vox, ved and vent) 
genes, which are required for ventral cell fate specification. Analternative explanation 
is the expression of nanog in the yolk blood vessel, playing an essential role in early 
yolk vein formation (vasculogenesis). This is likely; because there is evidence that 
Nanog is present in porcine umbilical cord (PUC) matrix cells (Carlin et al., 2006) 
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and placenta (Siu et al., 2008). The fish yolk vein, the mammalian umbilical cord and 
placenta are all extra-embryonic tissues responsible for transporting nutrition or/and 
oxygen for the developing embryo. 
Ong protein is maternally stored in oocytes. To further uncover the roles of 
Nanog during early cleavage, we generated nanog dominant negative mutants: 
OngDN2 and OngDN3. Injection of OngDN2 mRNA led to embryo arrest at 
morula-blastula stage and died, which is reminiscent of nanog-/- mouse embryo 
phenotype. A detail examination revealed that the arrested embryo did form YSL. 
Injection of OngDN3 mRNA produce mild phenotype: embryos can enter gastrulation 
stage but the blastomeres were enlarged and disorganized or the enlarged cell were set 
aside of the anterior-posterior axis. What is the property of these enlarged cells? It is 
possible that these enlarged cells have lost their pluripotency and proliferation ability.  
The CD2 domain (enrichment of aromatic acids) of mouse nanog is a strong 
transactivator and is required for nanog-mediated self renewal (Wang et al., 2008b). 
Mouse Nanog usually functions by homodimer through the CD domain. It helps us to 
explain why lack of CD2 causes strong dominant negative effect. 
3.2.8 Ong function in medaka ES cells 
The presence of nanog is always associated with ES cells. The simultaneous 
expression of Nanog, Oct4 and Sox2 indicates the (ES) cells are pluripotent. Gain of 
function has demonstrated nanog promotes cell proliferation and plays global roles in 
preventing differentiation (Chambers et al., 2003). Nanog was firstly demonstrated to 
be required for maintaining mouse ESCs pluripotency because nanog-/- ES cells 
 121
differentiate toward extraembryonic endoderm lineage (Mitsui et al., 2003). However, 
later in 2007, Chambers et al showed that nanog null ES cells could colonize 
embryonic germ layers and exhibit multilineage differentiation both in fetal and adult 
chimeras. It seems that nanog is not required for determining the ES cell fate and 
housekeeping machinery of pluripotency but acts primarily in construction of inner 
cell mass and germ cell states (Chambers et al., 2007). But more evidence supports 
that nanog is required for maintaining ES cells pluripotency (Hough et al., 2006; 
Hyslop et al., 2005; Ivanova et al., 2006; Lavial et al., 2007; Vallier et al., 2009; Xu et 
al., 2008).  
Medaka ES cells do express nanog abundantly. Upon MES1 differentiation, 
nanog mRNA level decreases accordingly. Constitutive overexpression of Ong 
supports long-term proliferation of MES1 in the absence of bFGF, which is required 
for self-renewal of MES1 in ESM4. This is very similar to the case for mouse, human 
and chicken, where Nanog overexpression is able to maintain the undifferentiated 
state even without the presence of essential growth factors (Chambers et al., 2003; 








Chapter IV: Expression and function of zebrafish nanog 
4.1 Results 
4.1.1 Isolation of zebrafish nanog (Zng) 
Using medaka nanog amino acid sequence to do tBLSAT in zebrafish EST database, 
we get many clones, such as EF550998, BC162318, BC162315, EV557659, 
BG729388, and CD585806. Among them, EV557659 is from gonad or brain cDNA 
library (Sreenivasan et al., 2008) and CD585806 is from head-kidney marrow cDNA 
library (Song et al., 2004). Zng cDNA full length is at least 1892 bp encoding a 
peptide of 384 amino acids (Fig. 4-1). Zng has 4 exons and was mapped to 
chromosome 24 (locus, zgc:193933). Zng gene structure is similar to Ong in medaka 
that has been demonstrated in chapter III (Fig. 3-4).  
4.1.2 Expression analysis of Zng 
4.1.2.1 Expression of Zng by RT-PCR. 
To examine Zng expression pattern in adult tissues, RT-PCR analysis was performed. 
The forward primer start2 (GAGCGCTTCAATCAGCATCC) was from 5’UTR region 
and reverse primer E2R (GTTAAGTTCCGTTCTCCACTGTC) was from exon2 (Fig. 
4-1). A fragment of 609 bp was amplified. As shown in Fig. 4-2, it iwas detected in 
brain, kidney, testis and ovary, coinciding with the digital data. 
   Zng transcripts are present as maternal message (EST data, EF550998). From 1-cell 
stage to bud stage it was abundantly expressed. After bud stage, its expression 
decreases. From 2-day onwards, Zng transcripts were barely detectable (Fig.4-2).  
4.1.2.2 Expression of Zng in adult tissues by ISH. 
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To further investigate which cell types possess the mRNA signal, we applied ISH 
techniques. Zng transcripts were detected in pre-vitellogenic oocytes (Fig. 4-3 A, B). 
During oogenesis, Zng is abundantly expressed in oocytes cytoplasm with no obvious 
subcellular localization. In adult testis, the signals mainly reside in periphery 
cells--putative spermatognia stem cells (Fig. 4-3C). In kidney, Zng transcript is 
present in cells around the mesonephric tubules (Fig. 4-3D) 
4.1.2.3 Spatial expression of Zng in early embryos by WISH. 
WISH on early embryos was performed to examine the expression of Zng. Zng 
transcripts were detected at 1-cell stage (Fig. 4-4), further demontrating its maternal 
expression. From 2- cell to 512-cell stage, Zng transcripts are abundantly expressed. 
Upon onset of gastrulation, the level of Zng transcript begins to decrease. Until 80% 
epiboly, it was undetectable. Nevertheless, prolong staining at 4 ˚C still could give 
rise to signal (data not shown). Because RT-PCR results suggested Zng was expressed 
during somitogenesis stage, detail examination was done at 14 hpf by prolonged 
staining. At 14 hpf, Zng transcripts were detected in the developing head and tail. 
Surprisingly, Zng transcripts were detected in putative yolk blood vessel and brain at 







Fig. 4-1 Zng cDNA sequence with deduced anmino acid sequence. The Zng cDNA 
has an open reading frame encoding 384 amino acids. The Zng gene has four exons 
that are highlighted alternatively in grey color. The homeodomain amino acid 
sequence and putative ployadenylation signal sequence are bolded. Primers for 





                                                                           Start2 
1    TAAATCAGCATATCCACACATTTTTTACATCAGGTGATGTAAATGGGTCGGTAATTGTTACTATGAGGAGGAGCGCTTCAATCAGCATCC 
                                                                     MO2 
91   GTTTTCGAGGGTAGTCGAGCCCTTTGGGTTTTTTTTTTTAGTAGTCCGGTTTTTTTTAATTAGGTGTTTAGTACGTTACTTTCTGCTTGA 
                  MO1 
181  GTTTATCTAACGGCGAAATGGCGGACTGGAAGATGCCAGTGAGTTACAATTTTAACCCATCTTATCATGCATATGCATACGGGCTCATGT 
                       M  A  D  W  K  M  P  V  S  Y  N  F  N  P  S  Y  H  A  Y  A  Y  G  L  M    
271  ACCCGCAAGTGTCAGAGCACGGCGTCCCGAATCTGAGCTGGCCCGATGCCGCGTACACACACTCCGGCGGGGTCACAGCGGGCTACTTTA 
   Y  P  Q  V  S  E  H  G  V  P  N  L  S  W  P  D  A  A  Y  T  H  S  G  G  V  T  A  G  Y  F    
361  CCGCTCAAACTGCACAGTCGCCACCCTGGAGCCCGGAGAACGGCGGCGCCCCCATCACCTACAGCCAGTACCCGGGACACTCGCAGAACG 
 T  A  Q  T  A  Q  S  P  P  W  S  P  E  N  G  G  A  P  I  T  Y  S  Q  Y  P  G  H  S  Q  N    
451  GACGGCTCTTTCTGTCCTACAACAAGACTGAGCCCGACCAAAAGGCCAAAGATGCAGAGCAGACCAGCAGTGATACACCCAGTGATTCCG 
  G  R  L  F  L  S  Y  N  K  T  E  P  D  Q  K  A  K  D  A  E  Q  T  S  S  D  T  P  S  D  S    
541  AGGCCCACACGCCAGATTCCTGGAGCTCAGCGAGCAGTCGAGAAGGGGTTCCTCTGACCAACCTCAATCTGCCATCCTGGAGAGATCGAG 
  E  A  H  T  P  D  S  W  S  S  A  S  S  R  E  G  V  P  L  T  N  L  N  L  P  S  W  R  D  R    
                                E2R 
631  ACTATGAAACAGACAGTGGTAGTCCTGACAGTGGAGAACGGAACTTAACCTCCACAGCAGGAGAGGAGCCAGTCAATCTGAATCTGGGGG 
 D  Y  E  T  D  S  G  S  P  D  S  G  E  R  N  L  T  S  T  A  G  E  E  P  V  N  L  N  L  G    
721  TCGATACCCAGCCTCCTCTGCCTGCATTGACTGCATCTCCTGTCCGGCCTCCGACCCTGCCCCGCAAGACCCGGGCTGCTTTTTCTGAAG 
  V  D  T  Q  P  P  L  P  A  L  T  A  S  P  V  R  P  P  T  L  P  R  K  T  R  A  A  F  S  E    
811  AACAGATGAATGCTTTGGTCAATCGGTTTAATGTCCAGAGATACCTCACGCCTGCAGAGATGAAAACGCTTGCTGGAGCAACAGGATTAA 
  E  Q  M  N  A  L  V  N  R  F  N  V  Q  R  Y  L  T  P  A  E  M  K  T  L  A  G  A  T  G  L    
901  CATACAAGCAGGTAAAAACATGGTTTCAGAACCGCAGGATGAAACTCAAGAGGCATCAGAGAGACAGCAGTTGGATGACTGAGAGATATG 
  T  Y  K  Q  V  K  T  W  F  Q  N  R  R  M  K  L  K  R  H  Q  R  D  S  S  W  M  T  E  R  Y    
991  TTGTCAATGCTGTACCCAACACACCAGCTTCTCAATCTCAGTTTCAGAGTGAACCCCCTGGAGCAAACCAAGACCACTACATTAACCCTC 
  V  V  N  A  V  P  N  T  P  A  S  Q  S  Q  F  Q  S  E  P  P  G  A  N  Q  D  H  Y  I  N  P    
1081 AGGTGAGAGAACCTGTTTTCAAGAGGAGTCCTCCAAAAACACCCTTCTACCCCAGTTACCCACAGCCACGCTCCCCAACACAGGCCACCT 
  Q  V  R  E  P  V  F  K  R  S  P  P  K  T  P  F  Y  P  S  Y  P  Q  P  R  S  P  T  Q  A  T    
1171 CGAGACCCCCAGGAACCTGGCCTCTGCCCCCAGCTGTGACGCACTATGAGTTCCCCAACCCCATCAGCTACATGCCAGCACGTGATGGCA 
  S  R  P  P  G  T  W  P  L  P  P  A  V  T  H  Y  E  F  P  N  P  I  S  Y  M  P  A  R  D  G    
1261 GCAATGCAGTGAACAAAGAAAGCAGCCCTTCTCCGCTGGCAACTTCGCCTACTGCTGGCCTGTGGGCAACTAAAGGAATAACTTTGCTGT 
 S  N  A  V  N  K  E  S  S  P  S  P  L  A  T  S  P  T  A  G  L  W  A  T  K  G  I  T  L  L    
1351 GACCAGCTGCTTCGTGTATTTTATCAATCTTCAGCCACACAGCCTTCAGTCTTCTTGTTTGTAAATAATTTTTTGGCAACACGTTGGATA 









Fig. 4-2 Spatial and temporal expression of Zng. (A) Zng is expressed in adult 
gonads, kidney and brain. (B) Zng is abundantly expressed throughout the first 24h 
embryogenesis. After 24 hpf, the expression deceases and is barely detectable after 2 













Fig. 4-3 Zng RNA expression in adult tissues. (A-B) Ovarian sections. Zng 
expression is clearly visible in stage I to III oocytes but undetectable in stage IV 
oocytes due to dilution by yolk material. (C) Testicular section showing Zng 
expression in the peripheral region rich in male germ stem cells spermatogonia (sg). 
(D) Kidney section showing Zng expression in islands of interrenal cells surrounding 









Fig. 4-4 Zng mRNA is maternally supplied. WISH showing strong and uniform Zng 





Fig. 4-5 Zng RNA expression in early embryonic stages from MBT to 24 hpf. Zng 
mRNA expression decreases from high stage to shield stage. At shield stage, Zng 
transcripts present in shield region (arrow). At 80% epiboly, Zng transcripts are not 
detected by normal staining at 37 ˚C for 30 minutes (prolonged staining overnight can 
give signals, data not shown). Arrows show the blastopore edge. At 14 hpf, the Zng 
mRNA is mainly expressed in developing head and tail region. At 24 hpf, signals 
reside in brain (mb, middle brain), eyes (ey) and putative yolk blood vessel (yv). 
Signals at 14 and 24 hpf stages were given by staining overnight at 4 ˚C. 
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4.1.3 Functional analysis of MO knockdown of Zng 
To study the function of Zng in early development, antisense MO knockdown was 
performed. Two MOs (MO1: GGCATCTTCCAGTCCGCCATTTCGC; MO2: 
GCAGAAAGTAACGTACTAAACACCT) were designed to inhibit Zng mRNA 
translation. MO1 and MO2 caused similar phenotype but MO1 was more sensitive. 
MO2 needs double dose of MO1 to get the same phenotype. MO1 was preferred in 
this study. 
Zng morphants demonstrated dosage-dependent phenotypes. The phenotypes 
were roughly classified into five categories. The mild morphant (Class I) showed an 
eyeless phenotype with heart edema and loss of circulation. Class II morphant showed 
a phenotype of eyeless and dorsal tail fin defects. Severe phenotype (class III) 
displayed a phenotype of eyeless, bent tail and tail fin defects. More severe phenotype 
(class IV) displayed folded tail or curled tail or no tail. The most severe class (V) 
resembled the dorsalized C5 without visible tail and head structures (Fig. 4-6). The 
phenotypes are accumulating from class I to IV. In all classes, eyeless and loss of 
circulation are the most sensitive phenotypes. Loss of circulation is largely caused by 
yolk vein missing, because the blood vessels in the embryo body are normal by 
fli1:egfp transgenic zebrafish analysis (data not shown). These are different from the 
typical dorsalized phenotype. Only the most severe phenotype (class V) was very 




















0.5 224 12 121(54%) 65(29%) 18 2 3 3 
0.6 213 5 62(29%) 102(48%) 31(15%) 3 8 2 
0.7 257 4 6 54(21%) 136(53%) 25(9%) 21(8%) 11 
1.0 215     70(33%) 120(56%) 25 
1.5 228      178(78%) 50(22%) 
Embyos died before the blastula were not counted. 
 
After MO injection the embryos were monitored from sphere stage to 48 hpf. 
When the injection dose was above 1.0 ng, various gastrulation defects were noted 
(Fig. 4-7). At 10 hpf, the morphants displayed delayed epiboly and usually reached 
70% epiboly. This epiboly defect may affect the formation of tail organizer and partly 










Fig. 4-6 Phenotypes caused by Zng MO knockdown. (A-B) control embryos. Class 
I (C-F): Morphants displayed eyeless, shorter body axis, heart edema, loss of 
circulation and less pigment at 48 hpf. (F) Upper embryo is control. Class II (G): 
dorsal tail fin defects with ball-like structures (white arrows). Class III (H): bent tail. 
Class IV: serious tail defects such folded tail or curled tail. Class V: no head, no tail. 
Representatives of phenotypes are arranged according to severity from class I (0.5 ng 




Fig. 4-7 Zng knockdown leads to gastrulation defects. (A) Control embryo reaching the 
tail bud stage at 10 hpf. (B-F) Gastrulation defects at 10 hpf. (B) Incomplete epiboly. (C) 
Exogastrulation. (D-E) Cells during epiboly were enlarged and disorganized. (F) Sorted 










4.1.4 Rescue of MO knockdown phenotypes by Ong and mouse nanog. 
From the view of phenotypes caused by MO knockdown, Ong shows subatantial 
differences with its zebrafish homolog. To demonstrate that Zng is a functional 
homolog of mouse and medaka, we used Ong and mouse nanog to rescue zebrafish 
morphants. At a dose of 0.7 ng MO1 injection, over 90% embryos displayed eyeless 
phenotype. Coninjection of 0.7 ng MO1 and 200 pg Ong mRNA led to 95% (n=98) 
morphants with eyes. The rescue for eyeless phenotype is obvious (Fig. 4-8, Table 
4-2). Although the tail defect can be resued to a lesser extent (31%, n=98), a point 
must be considered, i.e., overexpression of Ong can result in severe tail defects. 
Mouse nanog also can rescue the eyeless phenotype to some extent (57%), but 
produce cyclopia (12%) (Fig. 4-9, Table 4-2). 
 
Table 4-2 Phenotypic rescue by medaka and mouse nanog* 
Eyed embryos Injection Embyros 
observed 
Eyeless 
n (%) Two eyes cyclopia 
MO1 58 53 (91) 3(5) 0 
MO1 + ong 98 3(3) 93(95) 2(2) 
MO1 + mng 98 30(30) 56(57) 12(12) 
*Zygotic injection with 0.7 ng MO1/embryo alone or with 0.4 ng of ong and mouse 






Fig. 4-8 Eyeless phenotype can be rescued by Ong mRNA injection. (A, C) 
Embryos were injected with MO1 only. (B, D) Embryos were injected with MO1 and 
Ong mRNA. (D) At 36 hpf, rescued embryos had black eyes (arrow), albeit that some 
embryos still had tail defects (arrow head). (C) Embryos injected with MO only had 









Fig. 4-9 Eyeless phenotype can be rescued by mouse nanog mRNA injection. 
Embryos injected with MO1 only lack black eyes at 48 hpf. Embryos injected with 













4.1.5 Mechanisms of DV and neuroectoderm patterning defects  
To gain further insights into the molecular mechanisms of DV patterning defects 
caused by Zng MO knockdown, markers for dorsal (gsc, pax2.1, pax6.1), ventral fate 
(vox, ved, vent, bmp4, bmp2b, bmp7) (see part 1.5.3 for detail introduction) or both 
(pou2, no tail, brachyury) were examined by ISH. The expression of vent family 
homeobox factors (vox, vent and ved) was clearly reduced by MO injection (Fig. 
4-10). At the high to sphere stage, vox was not initiated at all. At the sphere stage, 
both ved and vent expression was substantially reduced. At the shield stage, ved 
maintained markedly decreased expression and restricted its expression domain only 
to the ventral germ ring. Interestingly, the dorsal organizer marker goosecoid (gsc) 
was also reduced in morphants (Fig. 4-11), which is different from zebrafish pou2/spg 
(Reim and Brand, 2006). 
Pou2 is maternal factor for DV patterning. Loss of pou2 strongly dorsalized 
zebrafish embryos (Reim and Brand, 2006). Nanog can regulate mammalian Oct4 
(Boyer et al., 2005; Loh et al., 2006; Niwa et al., 2008). Upon Zng knockdown, the 
expression of zebrafish pou2, homolog of oct4, was considerablly reduced at the 
shield satge (Fig. 4-11). 
Zebrafish has two brachyury genes, no tail (ntl) and brachyury (Martin and 
Kimelman, 2008). Both are required for mesoderm formation. The tail defect in 
morphants may be related to these brachyury genes. At epiboly, both genes were 
misexpressed. The axial expression domain was enlarged while the expression in 
germ ring domain was disconnected (Fig. 4-12).  
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The mild phenotype is eyeless. Two eye field markers pax6.1 and pax2.1 were 
examined and both genes lost their expression in the retinal (Fig. 4-13), suggesting 
that nanog may regulate pax6.1 or other genes which are responsible for anterior 





















Fig. 4-10 Expression of vox, vent and ved by Zng MO1 knockdown. Compared to 
WT, at sphere stage, vox was not initiated. Ved and vent expression were largly 
reduced. At shield stage, ved expession was still largly reduced at ventral domain and 






Fig. 4-11 Expression of pou2 (oct4) and gsc by Zng MO1 knockdown. Both pou2 















Fig. 4-12 Mesodermal markers ntl and brachyury were misexpressed in Zng 
morphants at 80% epiboly. The axial expression domain was enlarged (parallel lines) 
while the expression in germ ring domain was no longer connected (arrow). Injected 








Fig. 4-13 Expression of pax6.1 and pax2.1 in eye field was lost in morphants. 
Morphants were eyeless and lost pax6.1 and pax2.1 expression in the eye field (black 








4.2.1 Zng is expressed in adult brain, kidney and gonad. 
Different from Ong, Zng is expressed in adult brain, head-kidney, testis and ovary. It 
is reasonable that Zng is expressed in testis and ovary where pluripotent cells populate. 
Expression in brain and kidney is a surprise but still explainable. Both brain and 
head-kidney (equivalent to human bone marrow) contain many multipotent stem cells. 
It was reported that nanog was indeed expressed in multipotent progenitor cells 
(MPCs) within human peripheral blood (Cesselli et al., 2009). It is very possible that 
Zng plays special roles in the fish context.  
4.2.2 Zng is maternally expressed in all blastomeres 
Unlike Ong, Zng is uniformly expressed in all blastomeres during cleavage stages. 
Even at shield stage, nanog transcripts can be easily detected in the whole epiblast. 
Zng is expressed in the shield region but not in primordial germ cells. This kind of 
expression is different from medaka nanog where expression was only found in 
central blastomeres and PGCs. It seems that Zng has other roles beyond maintaining 
pluripotency according to its expression pattern. This is very similar to zebrafish pou2 
(Reim and Brand, 2006; Takeda et al., 1994).  
4.2.3 Zng is weakly expressed in somitogensis stage 
Although Zng transcripts cannot be detected from 80% epiboly by normal staining 
procedure, qPCR suggests nanog is still expressed at a low level. We performed 
longer staining time at 4°C and found signal were given at anterior neural plate, tail 
bud region of 14 hpf embryo. For 24 hpf embryos, signals were given at developing 
 143
brain and yolk blood vessel. The signal in the yolk blood vessel is very interesting.  
4.2.4 Maternal Zng is required for neuroectoderm specification 
The most prominent phenotype is eyeless or headless and tail defect when 
translation-blocking MO was injected. However, splicing MO which only affects 
unprocessed transcripts and presumably not the maternal transcripts doesn’t cause 
eyeless phenotype but only tail defects. It was proposed that repression of Wnt, Nodal 
and BMP signal is required for brain specification and stimulation of BMP, Nodal and 
WNT8 is required for tail formation (Agathon et al., 2003). Currently there is a lot of 
evidence suggesting that the WNT pathway affects both neuroectoderm and tail 
patterning (Caneparo et al., 2007; Dorsky et al., 2003; Gestri et al., 2005; Hashimoto 
et al., 2000; Inbal et al., 2007; Kim et al., 2000; Kim et al., 2007; Lagutin et al., 2003; 
Seiliez et al., 2006; Shinya et al., 2000; Sun et al., 2006; Thorpe et al., 2005; 
Weidinger et al., 2005; Zhao et al., 2003). It is very likely that maternal Zng either 
activates Wnt antoganists or represses Wnt molecules or activates Wnt molecules with 
repressor activity before or during gastrulation to pattern neuroectoderm. 
4.2.5 Zng is required for tail formation 
Interestingly, Pou2 is required for ventral specification by activating BMP singal and 
vent family genes (Reim and Brand, 2006). However, Pou2 is not sufficient for 
initiating vox and bmp7 expression during MBT (Reim and Brand, 2006; Stickney et 
al., 2007). Here we found Zng is the factor for initiating vox expression and required 
for sustaining expression of ved and vent by cooperating with Pou2, Radar and Runx2 
(Flores et al., 2008; Sidi et al., 2003). 
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   Loss of Zng causes no tail expansion in the axial domain but misexpression in the 
germ ring domain. Although Pou2 also affects no tail expression, no evidence 
supports Pou2 repressing no tail directly. In Xenopus, Oct25 and Oct60 can repress 
xbra transcription by inhibiting FGF and Nodal signaling (Cao et al., 2006; Cao et al., 
2008). The cross talk of Oct25 and Nodal pathway is mediated by Smad2 (Cao et al., 
2008). Recently, Nanog was shown to bind Smad2 in human ES cells (Vallier et al., 
2009). It is possible that Zng may interact with Smad2/3 to regulate no tail expression 
because fish nanog appears to contain a putative smad4 homology domain in the 













Chapter V: General Discussion 
5.1 Why choosing fish nanog 
For many years, Xenopus and mouse are the major models in studying vertebrate 
development. Howerever, no ES cells have been isolated from Xenopus untill now. 
The reasons are still unknown, possibly because of reductive cleavage (Morrison and 
Brickman, 2006). In the past two decades, zebrafish and medaka have become 
popular vertebrate models (see introduction). Interestingly, stable ES like cell lines 
can be easily isolated from medaka but not zebrafish, suggesting significant 
differences exist between the two bony fish models although they share similar 
genetic programs during very early development. The unsuccessful isolation of 
zebrafish ES cells limits its popularity in developmental biology, especially in the 
field of in vitro study. The successful isolation of medaka ES cells and incoming 
mature knockout techniques will provide us hope for establishing another in vitro 
model for functional analysis by genome modification. To this end, we must 
characterize our medaka ES cells at the molecular level. The pluripotency marker 
Oct4 and Nanog came into our view. However, several lines of evidence suggest the 
fish Pou2, homolog/paralog of Oct4, plays multiple roles other than maintaining 
pluripotency (Belting et al., 2001; Burgess et al., 2002; Hauptmann et al., 2002; 
Lunde et al., 2004; Morrison and Brickman, 2006; Niwa et al., 2008). To solve this 
issue, a detailed study on fish nanog is required.  
Unexpectedly, when or after we started our nanog project in 2005, there were 
some reports suggesting the non-existence of nanog homologs in fish genomes 
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(Canon et al., 2006; Lavial et al., 2007; Rodda et al., 2005). Out of confidence of the 
unique motif ‘YKQVKT’ in nanog homeodomain and the specific expression in 
tissues containing pluripotent cells, I continue to do my project regardless of digital 
prediction. Recently, the unique ‘YKQVKT” sequence has been demonstrated to be 
required for recognizing unique DNA binding sequence (Jauch et al., 2008) and to be 
a unique nuclear localization signal (Chang et al., 2009).  
5.2 Existence of fish nanog 
As discussed above, nanog is a divergent protein. Whether it exists across vertebrates 
should be considered carefully. There are several lines of evidence supporting the 
existence of nanog in lower vertebrate such as fish. First, identification of chicken 
nanog suggested that nanog is not unique to mammals (Lavial et al., 2007). Nanog 
from platypus (Orhithorhychus anatinus), a special egg-laying mammal, was also 
predicted. Both chicken and platypus nanog lack the ‘WXXX’ repeats in the 
C-terminus domain, suggesting the ‘WXXX’ repeats cannot be treated as a 
diagonostic character for nanog proteins and just a new character of higher mammals 
during evolution. Second, vertebrates (from fish to human) share very similar genetic 
program during early embryo development. The pathways (FGF, TGFβ and Wnt) 
which are responsible for embryo patterning are conserved. The core mechanisms of 
pluripotency and differentiation are also possibly conserved. The Oct4 and Sox2/Sox3 
(in fish, Sox3 is maternal while Sox2 is zygotic expression) homologues exist in fish 
and Xenopus and play essential roles during early embryo development, suggesting a 
nanog homolog exists in lower vertebrates such as fish. Third, nanog is expressed in 
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primordial germ cells. Factors controlling germ line development are usually 
conserved. 
5.3 Ong and Zng are homologues of mammalian nanog 
Although the fish nanog homologues do not possess conserved synteny structure, they 
have conserved gene and protein structure with similar expression and function. 
Based on genome data, they seem to be single-copy genes. We conclude that Ong and 
Zng are homologous to mammalian nanog.  
5.4 Divergence of nanog among vertebrates 
Nanog is a divergent homeobox protein with a unique motif sequence ‘YKQVKT’ in 
its homedomain (among all vertebrates examined, the only exception is YKQIKT in 
anole lizard). Its homeobox is very similar to NKx2.5, a master regulator in heart field, 
and vent, a transcription factor for specifying ventral cell fate. However, nanog is 
neither NKx2 family nor vent family. The unique sequence ‘YKQVKT’ is very 
interesting because it not only affects the nanog binding sequence but also confers 
nanog nuclear localization signal (Chang et al., 2009; Jauch et al., 2008). Inside the 
homeodomian, M31 (the 126 aa in mouse nanog) is another unique amino acid which 
exists only in nanog homologs (in chicken and platypus M is replaced by I). 
Following homeodomain, the first W in the C-terminal (in mouse, homeodomian ends 
at 155 aa by Q) is also unique to all nanog proteins. However, except these unique 
sequences and a Smad4 homology region with enriched serine in the N-terminal we 
cannot find more conserved sequences among vertebrates from teleost to human. 
Although the ‘WXXX’ repeats are conserved among higher mammals, they do not 
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exist in fish, chicken and platypus.  
5.5 Nanog regulates pluripotency or DV patterning 
As I am finishing my thesis manuscript, another study reported that fish nanog 
regulated proliferation only but not pluripotency (Camp et al., 2009). Their claims are 
different with our observations. Fish nanog does regulate cell proliferation, but it also 
regulates pluripotency and DV patterning. Firstly, loss of Ong results in elevated 
eomesodermin expression, a putative extraembryonic marker, suggesting Ong can 
regulate cell fate. This is similar to mouse, where loss of nanog causes ICM 
differentiation toward primitive endoderm lineage. Secondly, the vent family genes 
vent, vox and ved are also regulated by Zng or Ong, suggesting that fish nanog 
determines dorsal/ventral cell fate and regulates DV patterning. Ong knockdown leads 
to late blastula cells moving toward dorsal side but not ventral side because of 
reduced expression of ventral homeobx genes. Thirdly, Ong regulates pou2, 
brachyury and sox32 expression, suggesting nanog also regulate germ layer 
specification. Zng regulates pou2, pax6, pax2.1 and ntl expression, strongly 
supporting that nanog is required for lineage specification. Finally, the MO they used 
is the same to our MO1, which just causes mild phenotype. We resolved this issue 
with a second MO (OngMO2) and a dominant negative construct OngDN2. Taken 
together, fish nanog regulate pluripotency (including proliferation) and DV patterning. 
5.6 Models of Nanog function in fish. 
In medaka, Ong positively regulates pou2, vox and sox32 to pattern germ layers or 
ventral cell fate. Ong represses eomes to prevent blastomere differentiation (Fig. 
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5-1A). In zebrafish, Zng negatively regulates ntl to specify mesendoderm cell fate. 
Zng possiblely interacts with WNT/Tcf3 to pattern neuroectoderm cell fate by 
regulating pax6, pax2.1 and other genes (Fig. 5-1B). Importantly, Zng positively 




Fig. 5-1 Nanog regulates different sets of genes to control pluripotency or 
patterning. (A) Ong represses eomesodermin to maintain pluripotency of blastomeres. 
(B) Zng is required for neuroectoderm and dorsovental patterning. Both Ong and Zng 





Fig. 5-2 Regulation of ventral zygotic genes by maternal factors and zygotic 
wnt8/bmp2b. Nanog becomes one of the maternal factors regulating ventral zygotic 
gene expression. Ventral genes (bmp2b, bmp4, bmp7, vox, ved and vent) are activated 
by maternal factors Radar (grey), Runx2 (yellow orange), Pou2 (blue) and Nanog 
(green). When zygotic wnt8/bmp2b expression start, they dominantly regulate vent 
and vox expression. Zygotic ved is regulated by Runx2 and Nanog. Adapt from Flores 




Chapter VI: Conclusion and perspective 
6. 1 Conclusion 
Data obtained in this study lead to the following conclusions: 
 Ong (medaka nanog) and Zng (zebrafish nanog) posses conserved gene structure 
and unique nanog motif ‘YKQVKT’ in their homeodomains. 
 Ong expression is restricted to pluripotent cells, i.e. central blastomeres, PGCs, 
spermatogonia, oogonia, ES cells and GSCs, which is remiscent of mammalian 
nanog. 
 Ong full-length peptide was successfully expressed in E.coli and purified to 
produce an Ong antibody. Ong is localized to Balbiani body of stage I oocytes and 
nucleus of ES cells and primordial germ cells. 
 Zng has more broad expression domains including early blastomeres, developing 
brain, adult head-kidney and gonads. 
 Ong not only regulates cell proliferation but also maintains cell pluripotency. Ong 
overexpression can confer MES1 proliferation ability under culture conditions 
without the normally required growth factors (bFGF), which is remiscent of mouse 
Nanog (alleviation of LIF requirement when overexpressed). Loss of Ong results in 
compromised proliferation, delayed epiboly and tail defects. Ong is required to 
prevent central blastomere differentiation toward extraembryonic lineage (EVL and 
YSL) expressing eomes. 
 Zng is required for neuroectoderm and dorsoventral patterning. Loss of Zng 
results in eyeless phenotype and various tail defects. Both Ong and Zng are required 
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for dorsal/ventral cell fate determination by regulating ventral homeobox genes such 
as vox. 
 Ong is a pluripotency player while Zng is an embryo-patterning player. However, 
mouse Nanog (pluripotency player) can partially rescue both phenotypes caused by 
MO knockdown, suggesting that Nanog is functionally conserved in vertebrates albeit 
sequence divergence. It is possible that the patterning function of Nanog is produced 
by pleiotropy. 
 
6. 2 Perspective 
I have identified nanog homologs from two fish models and analyszed their function. 
Ong function is mainly to maintain cell pluripotency, while Zng function is to regulate 
neuroectoderm and dorsoventral patterning. Whether this difference is caused by 
function divergence or pleiotropy is unclear. In the future, more germ layer markers 
and downsteam target genes need to be examined. 
 Ong or Zng regulates a lot of target genes such as pou2, ntl, vox, pax6, sox32, 
eomes. Whether these regulations are mediated directly or indirectly is not known. To 
address this issue, LUC assay, Chip-seq or/and EMSA are required. 
 Ong is present in PGCs, but its function is not clear. MO knockdown results in 
somatic cell defects, limiting further analysis on germ cell development. Combination 
of rescue and splicing MO knockdown may provide some new insights into this issue. 
 According to our observation, Zng may also regulate cell proliferation; however, 
more evidence is required to reveal the multiple roles of Zng. 
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